
<html lang="en"     class="pb-page"  data-request-id="4becc6c1-f912-453f-9d47-e51f1af7a4a5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/jm8012823;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2009.52.issue-1;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Innovative Small Molecule Therapeutics" /></meta><meta name="dc.Creator" content="Magid  Abou-Gharbia" /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 10, 2008" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm8012823" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm8012823" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm8012823" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm8012823" /></link>
        
    
    

<title>Discovery of Innovative Small Molecule Therapeutics | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm8012823" /></meta><meta property="og:title" content="Discovery of Innovative Small Molecule Therapeutics" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm8012823"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm8012823">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm8012823&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm8012823&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm8012823&amp;href=/doi/10.1021/jm8012823" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 2-9</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm801525s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm801294h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Innovative Small Molecule Therapeutics</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Magid++Abou-Gharbia">Magid Abou-Gharbia</a></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Center for Drug Discovery Research, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, Pennsylvania 19140</span></div><div class="corresp-fn" id="afn1">â Contact information. Phone: (215) 707-4949. Fax: (215) 707-4701. E-mail: <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="59383b362c34383e192d3c3429353c773c3d2c77">[emailÂ protected]</a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm8012823&amp;href=/doi/10.1021%2Fjm8012823" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 2â9</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 10, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 October 2008</li><li><span class="item_label"><b>Published</b> online</span>10 December 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 January 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm8012823" title="DOI URL">https://doi.org/10.1021/jm8012823</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2%26pageCount%3D8%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMagid%2BAbou-Gharbia%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D1%26contentID%3Djm8012823%26title%3DDiscovery%2Bof%2BInnovative%2BSmall%2BMolecule%2BTherapeutics%26numPages%3D8%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9%26publicationDate%3DJanuary%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm8012823"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">12735</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">22</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm8012823" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Innovative Small Molecule Therapeutics&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Magid&quot;,&quot;last_name&quot;:&quot;Abou-Gharbia&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;2-9&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm8012823&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8012823&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8012823" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8012823&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8012823" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm8012823&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8012823" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm8012823&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm8012823&amp;href=/doi/10.1021/jm8012823" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm8012823" /></input><a href="/doi/pdf/10.1021/jm8012823" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm8012823&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm8012823%26sid%3Dliteratum%253Aachs%26pmid%3D19072120%26genre%3Darticle%26aulast%3DAbou-Gharbia%26date%3D2009%26atitle%3DDiscovery%2Bof%2BInnovative%2BSmall%2BMolecule%2BTherapeutics%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D1%26spage%3D2%26epage%3D9%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1a" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Opening Remarks</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Iâm honored and privileged to receive the prestigious Alfred Burger Award in Medicinal Chemistry and to join the list of distinguished individuals who received this honor before me. I regard this award as a reflection and recognition for the efforts of my research teams at Wyeth Research, for their creativity and dedication over the years, and for the contributions of many talented partners and collaborators who have made it possible for me to receive this important award. Over the years I have benefited from the advice and wisdom of many inspiring mentors and role models and am deeply indebted to all of them.</div><div class="NLM_p last">I share with you my journey working in Drug Discovery at Wyeth at the four discovery research sites over the past 2 decades and reflect on the evolution in medicinal chemistry approaches that have been successfully utilized in discovering todayâs innovative drugs.</div></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Todayâs innovative drug discovery is costly and time-consuming, with very few novel therapeutics making it to the market place. Traditional medicinal chemistry approaches adopted during the 1970s and 1980s were focused primarily on analoguing of endogenous ligands and industry leads.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Chemistry was low throughput and done iteratively, driven primarily by biochemical observations derived from animal testing. In contrast, the past decade has witnessed an evolution in medicinal chemistry approaches wherein automation has been effectively utilized in the synthesis of large numbers of analogues (combinatorial chemistry) and in the rapid screening of large numbers of compounds (HTS<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>).<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: 5-HT1A, 5-hydroxytryptamine subtype 1A; 5-HT2, 5-hydroxytryptamine subtype 2; 8-OH-DPAT, 8-hydroxy-2-(di-<i>n</i>-propylamino)tetralin; AD, Alzheimerâs disease; ADME, absorption, distribution, metabolism, and excretion; ADMET, absorption, distribution, excretion, and toxicity; AIDS, acquired immune difficiency syndrome; BACE, Î² amyloid converting enzyme; CNS, central nervous systerm; CoMFA, comparative molecular field analysis; CYP, cytochrome P450; D2, dopamine subtype 2; EPS, extrapyramidal side effects; HTS, high throughput screening; NCE, new chemical entity; NMR, nuclear magnetic resonance; SAR, structureâactivity relationship; SPR, structureâproperty relationship.</p></div></div><div class="NLM_p">At the turn of the century, subsequent to identification and characterization of large numbers of targets, the deciphering of the human genome led to an explosion in the â-omicsâ technologies. The assimilation of the resulting information and correlation of potential therapeutic targets with human diseases present tremendous challenges for drug research. Nonetheless, advances in technology have enabled the pharmaceutical industry to explore multiple medicinal chemistry approaches in support of chemical biology efforts and to identify leads and optimize drug candidates. These advances include improvements in structure-based design, integrating X-ray crystallography, computational chemistry, nuclear magnetic resonance spectroscopy, multivariate analysis, parallel synthesis, and early pharmaceutical profiling. Application of these techniques, coupled with the growing field of biosynthetic engineering, precise synthetic methods, and the use of high-resolution analytical tools, has also spurred renewed interest in natural-product-based drug research.</div><div class="NLM_p last">This lecture will give a brief overview of various medicinal chemistry approaches from the past to present that we utilized successfully to discover several marketed drugs and clinical candidates. These approaches include the following sections: (1) Ligand-Based Design, (2) Discovery of CNS Drug Candidates, (3) Multidimensional Lead Optimization, (4) Pharmaceutical Profiling, (5) Structure-Based Design, (6) Natural-Products-Based Drug Design, (7) Future Outlook.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Ligand-Based Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Ligand-based design, also referred to as pharmacophore-based design, capitalizes on the presence of existing structural similarities between a set of compounds and active ligands. The sources of active ligands vary and include literature, patents, and in-house experimental data of earlier lead compounds. This approach usually provides a good starting point for the chemist where the selected set of compounds is often more active than randomly selected compounds. The power of the pharmacophore-based approach for lead generation lies in its ability to identify diverse sets of compounds potentially possessing a desired biological activity but having different chemical scaffolds. This approach has been used extensively in the discovery of CNS therapeutics.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Discovery of CNS Drug Candidates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17362" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17362" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Design of therapeutics for treatment of CNS disorders has evolved from the early serendipitous discovery of chlorpromazine and benzodiazepine to current approaches utilizing ligand-based design. Alterations in biogenic amine neurotransmitter levels in the brain have been implicated in the pathophysiology and pharmacotherapy of a number of neurological and psychiatric disorders.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Over the years, the biogenic amines have provided medicinal chemists with a solid starting point for their design of innovative therapeutics (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0005.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biogenic amines as a starting point for drug design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Dopaminergic Drug Candidates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The dopamine hypothesis of schizophrenia has prompted vast research in an attempt to achieve normalization of dopaminergic activity. Studies have shown that neuroleptic therapy with antipsychotic drugs with apparent specificity for the limbic as opposed to the striatal region of the brain may provide efficacy with a lower risk of extrapyramidal side effects (EPS).<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> Our early research efforts in this area focused on developing novel atypical antipsychotic drugs that exhibited weak or moderate antagonist activity at D2 receptors as well as 5-HT2 antagonist activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> This work led to the design and discovery of two atypical antipsychotic agents: gevotroline <b>1</b> and carvotroline <b>2</b>. Both compounds demonstrated profiles in animal models of schizophrenia that suggested they might provide antipsychotic efficacy with reduced liabilities. For example, <b>1</b> and <b>2</b> blocked apomorphine-induced climbing in rats more potently than apomorphine-induced stereotypy and both compounds inhibited conditioned avoidance responding in rats and monkeys without inducing catalepsy.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Compounds <b>1</b> and <b>2</b> demonstrated antipsychotic activity in schizophrenic patients in phase II clinical trials.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> An alternative approach that we pursued for balancing the paradoxical dopaminergic activity in the cortical and limbic systems was to identify D2 partial agonists.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> CoMFA-driven SAR studies directed toward discerning the D2 receptor agonist pharmacohore and topography identified two advanced series, the 7-hydroxyaminochromans (7-OH-AMC) and the 7-hydroxyaminobezodioxans (7-OH-AMB),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and ultimately led to the discovery of the D2 partial agonist Aplindore<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> (DAB-452, <b>3</b>). Compound <b>3</b> demonstrated potent dopamine D2 receptor affinity and intrinsic activity between those seen with full agonists and the antagonist aripiprazole in a variety of in vitro assays and in an in vivo model of dopamine agonism. We hypothesized that the level of intrinsic activity seen with <b>3</b> should prove useful in modulating dopamine activity in conditions such as schizophrenia and provide dopaminergic tone in conditions where dopamine levels are low, such as in Parkinsonâs disease. Compound <b>3</b> advanced to phase II (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of dopaminergic drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Serotonergic Drug Candidates</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of the aminotetralin 8-OH-DPAT, a potent selective 5-HT1A full agonist, facilitated the development of several 5-HT1A ligands.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Our efforts in this area led to the discovery of 5-HT1A partial agonist zalespirone <b>4</b> and mixed 5-HT1A/5-HT2 antagonist adatanserin <b>5</b>; both demonstrated anxiolytic activity in animal models and advanced to phase II for the treatment of anxiety disorders.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16-20)</a></div><div class="NLM_p">Building upon structural features of <b>4</b> and <b>5</b> led to the discovery of a number of selective 5-HT1A antagonists, including WAY-100,635 (<b>6</b>) and lecozotan (<b>7</b>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The lack of intrinsic activity of <b>6</b> in multiple assay systems has made it a widely used pharmacological tool, but its poor oral bioavailability limited its clinical potential. Compound <b>7</b> was efficacious orally in reversing cognitive deficits in monkeys and advanced to phase II for the treatment of Alzheimerâs disease (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a></div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of serotonergic drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Multitarget ligand-based designs have been successfully utilized in the search for effective antidepressant drug candidates. While the majority of antidepressant research in the 1980s focused on design of novel selective serotonin reuptake inhibitors (SSRIs), we focused our efforts on the design of multitarget serotonin/norepinephrine reuptake inhibitors (SNRIs).</div><div class="NLM_p">We capitalized on the existing structural similarities between one of our earlier opiate analgesic leads, ciramidol, and antidepressants that were under clinical investigation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Ciramidol was further optimized (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) by reducing its chiral centers from three to one and incorporating an alkylamine pharmacophore in a three-step synthesis to afford Effexor (venlafaxine WY-45,030, <b>8</b>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0001.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structural Evolution of Effexor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>8</b> represented the first-in-class of SNRIs. It demonstrated efficacy in a broad range of patients including those that were difficult to treat. Since its launch in 1997 as Effexor XR, it has become the mainline therapy for major depressive disorders (MDD) and has been shown to have higher remission rates than SSRIs.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">The remarkable clinical efficacy of Effexor XR that has benefited over 15-million patients since its launch has prompted the search for a second generation SNRI. Consequently, Duloxetine was launched in 2004 and is reported to have more balanced affinities at the serotonin transporter (SERT) and norepinephrine transporter (NET). We observed that <b>8</b> is metabolized in the liver into three metabolites (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). One major metabolite, <i>O</i>-desmethyl venlafaxine (ODV) <b>9</b> is more bioavailable than Effexor and is also an inhibitor of both serotonin and norepinephrine reuptake.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Further investigation resulted in its FDA approval and launch in 2008 as Pristiq.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Major human metabolites of Effexor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Multidimensional Lead Optimization</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Drug discovery has undergone considerable changes during the past 2 decades as new enabling technologies have been introduced. These have provided us with new opportunities to increase drug discovery success and efficiencies on all levels. These new technologies not only assist in the optimization of biological properties of lead compounds but also allow the chemist to address pharmaceutical parameters and druglike physical properties earlier in the drug design process and on a much larger scale than was previously possible. In the past, selection and optimization of lead compounds and the selection of drug candidates were driven primarily by results from biological assays, but recently parallel druglike property optimization has added a new discovery dimension.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Pharmaceutical Profiling. StructureâProperties Relationship (SPR)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Druglike compounds are defined as those that have sufficiently acceptable chemicophysical and ADME properties and sufficiently acceptable toxicity to survive through the completion of human phase I clinical trials. Drug properties have always been a prominent component of the development phase, where detailed studies are performed on formulation, stability, PK, metabolism, and toxicity. However, in recent years it is has become imperative to integrate drug property evaluation into the discovery process. This has been achieved by building capability for measuring ensembles of essential âdruglike propertiesâ. This structureâproperty relationship (SPR) information complements traditional SAR information and is rapidly becoming an essential tool for medicinal chemists. It allows the chemist to address druglike properties earlier in the drug-design process as well as providing information that can help in the interpretation of results from in vitro and in vivo assays.</div><div class="NLM_p">In many instances poor efficacy in in vivo models may be due to low concentrations in the plasma and target tissues. This low bioavailability can be caused by a number of physical properties, such as poor solubility, poor permeability and absorption, active transport, and low metabolic stability.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> In particular, poor efficacy for CNS drug candidates in vivo may be caused by poor penetration of the bloodâbrain barrier (BBB) and/or low levels of free drug in the CNS. For CNS drug discovery, often the goal is to optimize unbound drug brain/plasma (B/P) ratios rather than total B/P ratios or total brain drug concentration.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">High throughput assays for physicochemical properties, solubility, permeability, lipophilicity, stability, and Pka-in vitro ADME (metabolism, transporters, protein binding, and CYP inhibition) and in vivo PK exposure, provided a wealth of data for the discovery scientists to make informed decisions (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). These assays complement the in silico approaches currently utilized to predict physicochemical parameters of molecules such as MetaSite.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High throughput screening of druglike properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Multidimensional optimization combining the physicochemical properties data with biological activity at the target site added tremendous value to the selection of development track candidates. The process is further guided by favorable PK and safety profiles and finding the suitable formulation for initiating first-in-human trials (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Multidimensional lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Structure-Based Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75066" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75066" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Rational drug design involves the use of three-dimensional information resulting from interactions of small molecules with biomolecules utilizing techniques such as X-ray crystallography and NMR spectroscopy. This approach has been successfully utilized in the discovery of several drug candidates, particularly the design of enzyme inhibitors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> In an effort to find effective therapies for treatment of inflammatory diseases, inhibition of TNF-Î± converting enzyme (TACE) represented an attractive drug discovery target for reducing the circulating level of the proinflammatory soluble protein TNF-Î±. Sulfonamide hydroxamate TACE inhibitor leads were further optimized for potency and selectivity over matrix metalloproteases (MMPs) utilizing information derived from X-ray cocrystal structures. The S1â² pocket of TACE consists of an initial region resembling the shallow S1â² pocket of MMP-1 in size and depth. The rest of the TACE S1â² is no longer extended linearly as in MMP-9 and MMP-13; rather, the extended channel is almost perpendicular to the S1â² pocket, directed toward the S3â² surface (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0011.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparing the active sites of MMPs and TACE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given this information and by use of a solid phase combinatorial chemistry approach, a series of phenoxyacetylene hydroxamates was synthesized. Optimizing these leads for potency and selectivity helped define the SAR requirements for the TACE binding site.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Subsequent optimization for PK and in vivo efficacy through parallel synthesis led to the discovery of TMI-005 <b>10</b>, a propargylic hydroxylhydroxyamic acid that advanced to phase II for treatment of rheumatoid arthritis (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0002.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Evolution of TMI-005</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Natural-Product-Based Drug Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Natural products and their derivatives have historically been invaluable as a source of innovative therapeutics. Natural-products-based drug discovery reached its peak during the 1970s and 1980s. Of the small molecule NCEs introduced to the market between 1981 and 2002, roughly half (49%) were natural products, semisynthetic natural product derivatives, or synthetic compounds based on natural product pharmacology.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a></div><div class="NLM_p">Despite this success, pharmaceutical research into natural products has encountered significant challenges during the past decade. In recent years, the pharmaceutical industry has placed low emphasis on natural-product-based drug discovery and several big pharma companies have exited natural product research. The decline in natural product research could be attributed to several factors such as lack of compatibility of traditional natural product extract libraries with HTS, demand on reducing hit-to-lead cycle time which favors screening of small molecule chemical libraries, waning interest in infectious disease research which is usually benefited from screening of natural products, development of combinatorial chemistry, and challenges in gaining access to biodiversity.</div><div class="NLM_p">Advances in technology have enabled natural-product-based drug discovery to operate on a more rational basis, and this has spurred renewed interest in natural products research which is now feasible using precise synthetic methods and high-resolution analytical tools.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Genetic engineering of biosynthetic pathways of biologically active natural product scaffolds can provide new starting points for optimization of these privileged structures.</div><div class="NLM_p">Natural-product-based drug discovery was successfully applied to rapamycin <b>11</b>, a novel immunosuppressant natural product with a unique mechanism.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It binds to the effector protein FKBP and forms a complex that binds to another effector protein, m-TOR<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (mammalian target of rapamycin, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Rapamycin was marketed in 1999 as Rapamune for treatment of transplantation rejection.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0012.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding of rapamycin to FKBP and mTOR42.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We embarked on a non-HTS approach looking at our rapamycin equity in order to expand its therapeutic utility. Applying a semisynthetic strategy to the C-42 secondary alcohol functionality led to the discovery of CCI-779 <b>12</b>, a cell cycle inhibitor with potent antitumor activity that was marketed in 2007 as Torisel for treatment of renal cell carcinoma<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0003.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Functionalization of C-42 Alcohol Led to the Discovery of Torisel</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The discovery of Torisel will be the subject of an upcoming case study perspective article.</div><div class="NLM_p">It is well established that immunophilins ligands such as FK-506 demonstrate neuroprotective activity in animal ischemia models. A key event in this process was thought to be binding to FKBP-12, which can trigger a cascade of events, although the exact mechanism is not fully known.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> One hindering factor to using these compounds as neuroprotectants has been their immunosuppressant activity. However, it is possible to achieve neuroprotection using immunophilins without immunosupression.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> Efforts aimed at exploring the role of these nonimmunosuppresive immunophilin ligands in neuroprotection revealed that, while binding to FKBP-12 was still a key step, formation of a ternary complex with calcineurin may not be responsible for mediating neuroprotection and neuroregeneration.</div><div class="NLM_p">Our efforts in designing non-immunosupressant neuroprotectant immunophilins focused on the pharmacophore that binds to the m-TOR effector protein. Structural manipulation targeting the C1âC4 triene of rapamycin utilizing DielsâAlder chemistry with a variety of dienophiles led to the synthesis of novel nonimmunosuppressant neuroprotective rapamycin derivatives. One of these, the semisynthetic adduct ILS-920 <b>13</b>, lacked immunosuppressant properties and demonstrated good brain penetration. It was synthesized in a three-step synthesis by reacting rapamycin with nitrosobenzene followed by hydrogenation of the six-membered cyclic adduct (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0004.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of ILS-920 (<b>13</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>13</b> promoted survival of E16 primary rat cortical neurons in culture and stimulated neurite outgrowth in that system (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The compound demonstrated neuroprotection in a rat transient mCAO focal ischemia model in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> In that model, animals treated with <b>13</b> showed reduced neurological deficits compared with placebo-treated animals, as measured by sensorimotor performance. In a permanent focal ischemia model, that improvement in sensorimotor performance compared to placebo lasted up to 3 months. Taken together, these data suggest that ILS-920 not only functions as a neuroprotectant but also promotes functional recovery. These exciting results will be featured in an upcoming manuscript.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Neuroprotective/neuroregenerative activity of compound <b>13</b> on E16 primary rat neurons in culture: (a) effect of <b>13</b> on neuronal survival; (b) compound <b>13</b> promoting neurite outgrowth.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>13</b> reduces infarct volume in a rat transient mCAO model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Graziani et al. have provided evidence that that the neuroprotective and neuroregenerative activities of <b>13</b> may involve binding to the effector protein, FKBP-52. In addition, inhibition of L-type calcium channel currents may contribute to the compoundâs neuroprotective activity.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div><div id="sec1_9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Closing Remarks and Future Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54042" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54042" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During my 26-year journey working in the pharmaceutical industry, I have experienced vast changes in medicinal chemistry approaches where new NCE drug candidates were discovered. Shifting emphasis from optimizing biology of synthesized molecules into optimizing druglike properties and the ADMET profile led to reduction in attrition rate of compounds in development. Current and future approaches include nontraditional approaches to the discovery of drug candidates. This will include bridging the gap between small-molecule and protein drug candidates by applying multiplatforms (small molecules, vaccines, and proteins) in an integrated strategy to tackle a given disease target. We have adopted this approach in applying our research capabilities to improve upon current approaches to AD treatment by utilizing multiple research platforms.</div><div class="NLM_p">In addition to developing drugs that more effectively control AD symptoms, we are expending significant resources on novel approaches to slow or halt the progression of the disease. We are using three technology platforms in our AD development efforts. Our small molecule approach involves designing Î³-secretase and BACE inhibitors to inhibit formation of Î²-amyloid protein (AÎ²). We have also taken a biopharmaceutical approach that involves designing recombinant proteins, vaccines, and human recombinant antibodies that stimulate the body to clear both soluble AÎ² and deposited Î²-amyloid (plaque) from the brain.</div><div class="NLM_p">Nontraditional approaches to natural-products-based drug discovery are now being adopted such as the use of fractionated libraries which result in broader assay compatibility and fewer interferences and lead to faster identification and isolation of active leads. Future natural products drug discovery leads not only will capitalize on semisynthetic approaches but will focus on a âcustomized natural products approachâ wherein new lead molecules once thought to be inaccessible by semisynthesis are generated through biosynthesis and genetic engineering. We successfully adopted both strategies that resulted in the discovery of the anticancer drug Torisel, neuroprotectant drug candidate ILS-920, and several new natural products derivatives currently in development.</div><div class="NLM_p">Fragment-based lead discovery is another emerging approach that is complementary to the traditional HTS strategy that is commonly used for hits (leads) identification. Fragment-based screening offers several advantages over HTS, such as screening smaller numbers of compounds (hundreds as compared to thousands in HTS). Compounds screened are usually of smaller molecular weights than compounds screened in HTS, and identified hits in fragment screening usually achieve higher binding efficiency but weaker potency than those identified via HTS. It is generally accepted that the fragment-based approach emphasizes efficiency and design while the HTS emphasizes affinity and number.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> It is also accepted that the fragment approach is more appropriate at the early stages of the optimization process given that rigorously defined criteria are established for the selection of targets subjected to this approach due to the constraint on X-ray crystallography and NMR resources.</div><div class="NLM_p">As more innovative new drugs acting at novel targets advance through development, it becomes increasingly important to establish a correlation between preclinical efficacy in animal models and efficacy in humans. Translational medicine is rapidly emerging in many biomedical research institutions as a tool to bridge this gap between preclinical and clinical studies, often referred to as âfrom bench to patient bedsideâ. Medicinal chemists are playing a pivotal role in the discovery of biomarkers, from radiolabeled synthesis efforts in imaging studies to the development of sophisticated instrumental analysis methods and biochemical assays in metabolomic investigation that are used to measure biomarker levels in biological fluids.</div><div class="NLM_p last">Thus, while drug discovery hurdles remain many and high, the future holds a great promise for this industry. We will continue discovering major breakthrough therapies that will address many unmet medical needs, such as disease-halting drugs for the treatment of Alzheimerâs disease, drugs to eradicate AIDS, and drugs to attack resistant cancers, treat strokes, MS, and other debilitating diseases.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36057" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36057" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Magid Abou-Gharbia</span> - <span class="hlFld-Affiliation affiliation">Center for Drug Discovery Research, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, Pennsylvania 19140</span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm8012823" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17"><b>Biography</b></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Magid Abou-Gharbia</b> received his B.Sc. (1971) and M.Sc (1974) degrees from Cairo University in Pharmacy and Pharmaceutical Sciences and his Ph.D. in Organic Chemistry from the University of Pennsylvania (1979) under the direction of Professor Madeleine Joullie. After an NIH postdoctoral fellowship at the Medical School and Chemistry Department at Temple University he joined Wyeth in 1982. He spent 26 years working in many therapeutic areas where he and his research team have made numerous contributions in medicinal chemistry that resulted in the discovery of several innovative marketed drugs, few of which are described in this article. In September 2008 he joined the School of Pharmacy at Temple University as Professor of Medicinal Chemistry and director of the Center for Drug Discovery Research (CDDR).</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The author is indebted to many Wyeth researchers who are responsible for the discovery of these many breakthroughs and first-in-class drug candidates. Sincere thanks go to my colleague Wayne Childers not only for providing constructive feedback and suggestions to the content of the presentation and this article but also for his dedicated tireless efforts in medicinal chemistry during the past 20 years. I also express my deep appreciation and thanks to Cynthia Tagliaferi for her efforts in preparing this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 51 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peretto, I.</span><span> </span><span class="NLM_article-title">Chemical strategies in early drug discovery: an overview of recent trends</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">677</span> <span class="NLM_lpage">684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=677-684&author=M.+Colomboauthor=I.+Peretto&title=Chemical+strategies+in+early+drug+discovery%3A+an+overview+of+recent+trends"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DPeretto%26aufirst%3DI.%26atitle%3DChemical%2520strategies%2520in%2520early%2520drug%2520discovery%253A%2520an%2520overview%2520of%2520recent%2520trends%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D677%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Fischer, J.</span><span> </span><span class="NLM_article-title">Analog-based drug research: lead and drug optimization</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">218</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1007%2Fs00044-004-0029-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=218-227&author=J.+Fischer&title=Analog-based+drug+research%3A+lead+and+drug+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00044-004-0029-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-004-0029-3%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DJ.%26atitle%3DAnalog-based%2520drug%2520research%253A%2520lead%2520and%2520drug%2520optimization%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2004%26volume%3D12%26spage%3D218%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span> </span><span class="NLM_article-title">Editorial overview: can drug discovery be industrialized?</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">283</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCksrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=283-284&author=P.+Gundauthor=E.+Maliskiauthor=F.+Brown&title=Editorial+overview%3A+can+drug+discovery+be+industrialized%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial overview: Can drug discovery be industrialized?</span></div><div class="casAuthors">Gund, Peter; Maliski, Ed; Brown, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-284</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFDEppr8MtIrVg90H21EOLACvtfcHk0ljoEBpmcFu6bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCksrk%253D&md5=09ac6b5d783104d4c6d0db99a000b169</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGund%26aufirst%3DP.%26aulast%3DMaliski%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DF.%26atitle%3DEditorial%2520overview%253A%2520can%2520drug%2520discovery%2520be%2520industrialized%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D283%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Stahl, S. M.</span> <span class="citation_source-book">Essential Psychopharmacology: Neuro Scientific Basis and Practical Applications</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2000</span>; Chapter 1, p  <span class="NLM_fpage">52</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=52&author=S.+M.+Stahl&title=Essential+Psychopharmacology%3A+Neuro+Scientific+Basis+and+Practical+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26btitle%3DEssential%2520Psychopharmacology%253A%2520Neuro%2520Scientific%2520Basis%2520and%2520Practical%2520Applications%26pub%3DCambridge%2520University%2520Press%26date%3D2000%26spage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">217</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F1568007043337373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15180482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=217-225&author=B.+Deanauthor=E.+Scarr&title=Antipsychotic+drugs%3A+evolving+mechanisms+of+action+with+improved+therapeutic+benefits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic drugs: Evolving mechanisms of action with improved therapeutic benefits</span></div><div class="casAuthors">Dean, B.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-225</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the conundrums of neuropharmacol. is to understand the therapeutic mechanisms of action of antipsychotic drugs.  Every drug with antipsychotic activity is a dopamine (DA) D2-like receptor antagonist and therefore this function is crit. to reducing psychotic symptoms.  However, the actions of the archetypal atypical antipsychotic drug clozapine go beyond antipsychotic effects because the drug is efficacious in treating psychotic symptoms that do not respond to drugs mainly directed at antagonizing the DA D2 receptor, has benefits in cognition, and has recently been shown to reduce levels of suicide.  A growing understanding of the mechanisms of clozapine and other atypical antipsychotic drugs suggests that both partial and inverse agonism, as well as receptor antagonism, at specific neurotransmitter receptors is required to give full therapeutic benefits.  It is, therefore, timely to review the evolving nature of the mechanisms of action of different antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KWcEfmek8bVg90H21EOLACvtfcHk0ljoEBpmcFu6bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7c%253D&md5=62dfdc336bd5ed2e0c412edfe4da90b5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568007043337373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337373%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DAntipsychotic%2520drugs%253A%2520evolving%2520mechanisms%2520of%2520action%2520with%2520improved%2520therapeutic%2520benefits%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D217%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Reynolds, G. P.</span><span> </span><span class="NLM_article-title">Receptor mechanisms in the treatment of schizophrenia</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">340</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1177%2F026988110401800303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15358977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsl2nu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=340-345&author=G.+P.+Reynolds&title=Receptor+mechanisms+in+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor mechanisms in the treatment of schizophrenia</span></div><div class="casAuthors">Reynolds, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-345</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There remain many limitations to the treatment of schizophrenia.  In addn. to the poor response of neg. and cognitive symptoms to antipsychotics, and the substantial proportion of poor- or non-responders, there are a variety of unpleasant and restricting side-effects of these drugs.  The introduction of several 'atypical' drugs, with diminished propensity to cause extrapyramidal motor effects (EPS), has greatly improved the tolerability of antipsychotic treatments.  The pharmacol. of atypical antipsychotics is varied and, although dopamine D2 receptor antagonism is common to all antipsychotics, the mechanisms of atypicality are complex and not fully understood.  Thus, antagonism at 5-HT2 and/or other receptors, weak dopamine receptor affinity and, most recently, partial agonism at dopamine D2 receptors, have been variously implicated.  However, because EPS have diminished with improvements in drug treatment, drug-induced wt. gain has emerged as a major concern, and the pharmacol. basis of this problem, involving effects at 5-HT2c and perhaps other receptors, is yielding to investigation.  Some drugs, notably the D2 partial agonists, can provide antipsychotic effects without the emergence of several of these problematic side-effects, which bodes well for future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiggMHmrWKx7Vg90H21EOLACvtfcHk0ljoEBpmcFu6bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsl2nu7o%253D&md5=6a83d8c0c99562441e27ba78b15dcb1b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F026988110401800303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110401800303%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26atitle%3DReceptor%2520mechanisms%2520in%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2004%26volume%3D18%26spage%3D340%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Antipsychotic activity of substituted Î³-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1987</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">1818</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1818-1823&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=M.+Webbauthor=J.+Moyerauthor=T.+Andreeauthor=E.+Muth&title=Antipsychotic+activity+of+substituted+%CE%B3-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a023%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DAntipsychotic%2520activity%2520of%2520substituted%2520%25CE%25B3-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1818%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">WY-47,384</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">541</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1988&pages=541-549&author=M.+Abou-Gharbiaauthor=T.+Andree&title=WY-47%2C384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DWY-47%252C384%26jtitle%3DDrugs%2520Future%26date%3D1988%26volume%3D13%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Behavioral pharmacology of the gamma carboline WY-47,384: a potential antipsychotic agent</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">11</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1988&pages=11-28&author=J.+Moyerauthor=M.+Abou-Gharbiaauthor=E.+Muth&title=Behavioral+pharmacology+of+the+gamma+carboline+WY-47%2C384%3A+a+potential+antipsychotic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DBehavioral%2520pharmacology%2520of%2520the%2520gamma%2520carboline%2520WY-47%252C384%253A%2520a%2520potential%2520antipsychotic%2520agent%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1988%26volume%3D13%26spage%3D11%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Psychotropic agents: synthesis and antipsychotic activity of substituted Î²-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1987</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">1100</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00389a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1100-1105&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=J.+Moyerauthor=E.+Muth&title=Psychotropic+agents%3A+synthesis+and+antipsychotic+activity+of+substituted+%CE%B2-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00389a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00389a022%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DPsychotropic%2520agents%253A%2520synthesis%2520and%2520antipsychotic%2520activity%2520of%2520substituted%2520%25CE%25B2-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1100%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">WY-47,791. Antipsychotic</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1991</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1008</span> <span class="NLM_lpage">1013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=1008-1013&author=M.+Abou-Gharbiaauthor=K.+Marquisauthor=T.+Andree&title=WY-47%2C791.+Antipsychotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DWY-47%252C791.%2520Antipsychotic%26jtitle%3DDrugs%2520Future%26date%3D1991%26volume%3D16%26spage%3D1008%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildersleeve, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochalski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">New generation dopaminergic agents. 2. Discovery of 3-OH-phenoxyethylamine and 3-OH-N1-phenylpiperazine dopaminergic templates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">295</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=295-300&author=R.+E.+Mewshawauthor=M.+Husbandsauthor=E.+S.+Gildersleeveauthor=M.+B.+Webbauthor=X.+Shiauthor=H.+Mazandaraniauthor=M.+I.+Cockettauthor=R.+Ochalskiauthor=J.+A.+Brennanauthor=M.+Abou-Gharbiaauthor=K.+Marquisauthor=J.+Coupetauthor=T.+Andree&title=New+generation+dopaminergic+agents.+2.+Discovery+of+3-OH-phenoxyethylamine+and+3-OH-N1-phenylpiperazine+dopaminergic+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DHusbands%26aufirst%3DM.%26aulast%3DGildersleeve%26aufirst%3DE.%2BS.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DOchalski%26aufirst%3DR.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DNew%2520generation%2520dopaminergic%2520agents.%25202.%2520Discovery%2520of%25203-OH-phenoxyethylamine%2520and%25203-OH-N1-phenylpiperazine%2520dopaminergic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochalski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structureâactivity relationships of a series of 2-aminomethyl chromans</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">40</span> <span class="NLM_fpage">4235</span> <span class="NLM_lpage">4256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9703653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4235-4256&author=R.+E.+Mewshawauthor=J.+Kavanaghauthor=G.+Stackauthor=K.+L.+Marquisauthor=X.+Shiauthor=M.+Z.+Kaganauthor=M.+B.+Webbauthor=A.+H.+Katzauthor=A.+Parkauthor=Y.+H.+Kangauthor=M.+Abou-Gharbiaauthor=R.+Scerniauthor=T.+Wasikauthor=L.+Cortes-Burgosauthor=T.+Spanglerauthor=J.+A.+Brennanauthor=M.+Pieslaauthor=H.+Mazandaraniauthor=M.+I.+Cockettauthor=R.+Ochalskiauthor=J.+Coupetauthor=T.+H.+Andree&title=New+generation+dopaminergic+agents.+1.+Discovery+of+a+novel+scaffold+which+embraces+the+D2+agonist+pharmacophore.+Structure%E2%88%92activity+relationships+of+a+series+of+2-aminomethyl+chromans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm9703653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9703653%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DKavanagh%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DKagan%26aufirst%3DM.%2BZ.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DKatz%26aufirst%3DA.%2BH.%26aulast%3DPark%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DY.%2BH.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DWasik%26aufirst%3DT.%26aulast%3DCortes-Burgos%26aufirst%3DL.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DOchalski%26aufirst%3DR.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DNew%2520generation%2520dopaminergic%2520agents.%25201.%2520Discovery%2520of%2520a%2520novel%2520scaffold%2520which%2520embraces%2520the%2520D2%2520agonist%2520pharmacophore.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520series%2520of%25202-aminomethyl%2520chromans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4235%26epage%3D4256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Heinrich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hormby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pausch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Aplindore (DAB-452): a high affinity selective dopamine D2 partial agonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">552</span> <span class="NLM_fpage">36</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1016%2Fj.ejphar.2006.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17056032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmurvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2006&pages=36-45&author=J.+N.+Heinrichauthor=J.+Brennanauthor=M.+H.+Laiauthor=K.+Sullivanauthor=G.+Hormbyauthor=M.+Popiolekauthor=L.-X.+Jiangauthor=M.+H.+Pauschauthor=G.+Stackauthor=K.+Marquisauthor=T.+H.+Andree&title=Aplindore+%28DAB-452%29%3A+a+high+affinity+selective+dopamine+D2+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist</span></div><div class="casAuthors">Heinrich, Julia N.; Brennan, Julie; Lai, Margaret H.; Sullivan, Kelly; Hornby, Geoff; Popiolek, Mike; Jiang, Li-Xin; Pausch, Mark H.; Stack, Gary; Marquis, Karen L.; Andree, Terrance H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">36-45</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacol. of aplindore (DAB-452) was characterized in CHO-K1 cells stably transfected with the human dopamine D2 receptor short isoform (CHO-D2s) and in a behavioral model for postsynaptic agonism in rats.  In [3H]-spiperone competition binding studies, aplindore showed high affinity for dopamine D2 and D3 receptors and low affinity for the dopamine D4, serotonin (5-HT)1A, 5-HT2 receptors and the Î±1-adrenoceptor.  The high potency partial agonist activity of aplindore was demonstrated in [35S]guanosine 5'-O-(3-thiotriphosphate) ([35S]GTPÎ³S) binding, extracellular signal-regulated kinase (ERK)-phosphorylation and intracellular calcium flux assay using fluorometric plate reader ([Ca2+]i-FLIPR) format.  The [Ca2+]i-FLIPR assay was conducted with CHO-D2S receptor cells also stably expressing chimeric GÎ±q/o-proteins.  In all assay modalities, the potencies and intrinsic activities of aplindore were lower than dopamine and higher than aripiprazole.  In contrast to the [35S]GTPÎ³S binding and ERK-phosphorylation assays, the [Ca2+]i-FLIPR assay was able to detect the low partial agonist activity of SDZ 208-912.  In unilaterally 6-hydroxydopamine (6-OHDA) lesioned rats, aplindore induced contralateral turning, which was blocked by the dopamine D2 receptor antagonist raclopride.  The dopamine D2 receptor selective partial agonist profile of aplindore suggests that it should be effective for the treatment of dopaminergic-based disorders, such as schizophrenia and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLHRpcmHQzCbVg90H21EOLACvtfcHk0lhPq0BBD01atg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmurvK&md5=b40dfb12115516073cb16c548432461b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BH.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DHormby%26aufirst%3DG.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DL.-X.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DAplindore%2520%2528DAB-452%2529%253A%2520a%2520high%2520affinity%2520selective%2520dopamine%2520D2%2520partial%2520agonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D552%26spage%3D36%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Arvidsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span> </span><span class="NLM_article-title">8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">921</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00140a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=921-923&author=L.+E.+Arvidssonauthor=U.+Hacksellauthor=J.+L.+Nilssonauthor=S.+Hjorthauthor=A.+Carlssonauthor=P.+Lindbergauthor=D.+Sanchezauthor=H.+Wikstrom&title=8-Hydroxy-2-%28dipropylamino%29tetralin%2C+a+new+centrally+acting+5-hydroxytryptamine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00140a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00140a002%26sid%3Dliteratum%253Aachs%26aulast%3DArvidsson%26aufirst%3DL.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DD.%26aulast%3DWikstrom%26aufirst%3DH.%26atitle%3D8-Hydroxy-2-%2528dipropylamino%2529tetralin%252C%2520a%2520new%2520centrally%2520acting%25205-hydroxytryptamine%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D921%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structureâactivity relationship studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">1382</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00402a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1382-1392&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=M.+Webbauthor=J.+Moyerauthor=T.+Andreeauthor=E.+Muth&title=Polycyclic+aryl-+and+heteroarylpiperazinyl+imides+as+5-HT1A+receptor+ligands+and+potential+anxiolytic+agents%3A+synthesis+and+structure%E2%88%92activity+relationship+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00402a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00402a023%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DPolycyclic%2520aryl-%2520and%2520heteroarylpiperazinyl%2520imides%2520as%25205-HT1A%2520receptor%2520ligands%2520and%2520potential%2520anxiolytic%2520agents%253A%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1382%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Haskins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span> </span><span class="NLM_article-title">Preclinical anxiolytic profile of the pyrimidinylpiperazinyl imide compound WY-47,846</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1989&pages=29&author=J.+T.+Haskinsauthor=J.+A.+Moyerauthor=T.+H.+Andreeauthor=E.+A.+Muthauthor=M.+Abou-Gharbia&title=Preclinical+anxiolytic+profile+of+the+pyrimidinylpiperazinyl+imide+compound+WY-47%2C846"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaskins%26aufirst%3DJ.%2BT.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26atitle%3DPreclinical%2520anxiolytic%2520profile%2520of%2520the%2520pyrimidinylpiperazinyl%2520imide%2520compound%2520WY-47%252C846%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1989%26volume%3D18%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskins, J. T.</span><span> </span><span class="NLM_article-title">WY-47,846</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">14</span><span class="NLM_issue">5</span> <span class="NLM_fpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=442&issue=5&author=M.+Abou-Gharbiaauthor=J.+Moyerauthor=J.+T.+Haskins&title=WY-47%2C846"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DHaskins%26aufirst%3DJ.%2BT.%26atitle%3DWY-47%252C846%26jtitle%3DDrugs%2520Future%26date%3D1989%26volume%3D14%26issue%3D5%26spage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span> </span><span class="NLM_article-title">WY-50,324, anxiolytic/antidepressant</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">15</span><span class="NLM_issue">11</span> <span class="NLM_fpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1990&pages=1093&issue=11&author=M.+Abou-Gharbiaauthor=J.+Moyer&title=WY-50%2C324%2C+anxiolytic%2Fantidepressant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26atitle%3DWY-50%252C324%252C%2520anxiolytic%252Fantidepressant%26jtitle%3DDrugs%2520Future%26date%3D1990%26volume%3D15%26issue%3D11%26spage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharik, R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span> </span><span class="NLM_article-title">Sythesis and SAR of adatanserin: novel adamantly aryl- and heteroarylpiperazines with dual 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">5077</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9806704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5077-5094&author=M.+Abou-Gharbiaauthor=W.+Childersauthor=H.+Fletcherauthor=G.+McGaugheyauthor=U.+Patelauthor=M.+Webbauthor=J.+Yardleyauthor=T.+Andreeauthor=C.+Boastauthor=R.+Kucharikauthor=K.+Marquisauthor=M.+H.+Husbandsauthor=R.+Scerniauthor=J.+Moyer&title=Sythesis+and+SAR+of+adatanserin%3A+novel+adamantly+aryl-+and+heteroarylpiperazines+with+dual+5-HT1A+and+5-HT2+activity+as+potential+anxiolytic+and+antidepressant+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9806704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9806704%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DYardley%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DBoast%26aufirst%3DC.%26aulast%3DKucharik%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DHusbands%26aufirst%3DM.%2BH.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DJ.%26atitle%3DSythesis%2520and%2520SAR%2520of%2520adatanserin%253A%2520novel%2520adamantly%2520aryl-%2520and%2520heteroarylpiperazines%2520with%2520dual%25205-HT1A%2520and%25205-HT2%2520activity%2520as%2520potential%2520anxiolytic%2520and%2520antidepressant%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5077%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potestio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schecter, L. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of benzodioxanylpiperazines as potent serotonin 5-HT1A antagonists: the discovery of lecozotan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span><span class="NLM_issue">10</span> <span class="NLM_fpage">3467</span> <span class="NLM_lpage">3470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049493z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3467-3470&issue=10&author=W.+E.+Childersauthor=M.+G.+Kellyauthor=M.+A.+Abou-Gharbiaauthor=T.+H.+Andreeauthor=B.+L.+Harrisonauthor=G.+Hornbyauthor=L.+Potestioauthor=S.+J.+Rosenzweig-Lipsonauthor=J.+Schmidauthor=D.+L.+Smithauthor=S.+J.+Sukoffauthor=G.+Zhangauthor=L.+E.+Schecter&title=Synthesis+and+biological+evaluation+of+benzodioxanylpiperazines+as+potent+serotonin+5-HT1A+antagonists%3A+the+discovery+of+lecozotan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049493z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049493z%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DPotestio%26aufirst%3DL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%2BJ.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchecter%26aufirst%3DL.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520benzodioxanylpiperazines%2520as%2520potent%2520serotonin%25205-HT1A%2520antagonists%253A%2520the%2520discovery%2520of%2520lecozotan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D10%26spage%3D3467%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Lecozotan</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">32</span> <span class="NLM_fpage">399</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1358%2Fdof.2007.032.05.1092901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=399-407&author=W.+E.+Childersauthor=B.+L.+Harrisonauthor=M.+A.+Abou-Gharbiaauthor=S.+Rajeauthor=V.+Parksauthor=M.+N.+Pangalosauthor=L.+E.+Schechter&title=Lecozotan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition enhancer treatment of Alzheimer's disease competitive 5-HT1A receptor antagonist</span></div><div class="casAuthors">Childers, Wayne E., Jr.; Harrison, Boyd L.; Abou-Gharbia, Magid A.; Raje, Sangeeta; Parks, Virginia; Pangalos, Menelas N.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Lecozotan is a potent, selective, competitive, orally active antagonist of the serotonin 5-HT1A receptor in development for the symptomatic treatment of cognitive deficits such as those seen in Alzheimer's disease.  The agent shows no intrinsic activity in a no. of in vitro and in vivo assays, supporting the conclusion that it is a full antagonist under several conditions.  In vivo, lecozotan enhances the potassium-stimulated release of both acetylcholine and glutamate, and it improves cognitive performance in multiple animal models of learning and memory.  The compd. was well tolerated in single- and multiple-ascending-dose (SAD and MAD) safety trials in both young and elderly subjects at total daily doses up to and including 10 mg (5 mg every 12 h) for the immediate-release formulation.  Sustained-release formulations have been developed which provide favorable pharmacokinetics for once-daily dosing.  Lecozotan is currently under investigation in advanced phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzPkCOymtxrVg90H21EOLACvtfcHk0lja20NA8tmEmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D&md5=5149bb9b594cbc636ef22b9e7f57f10c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.05.1092901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.05.1092901%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DParks%26aufirst%3DV.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DLecozotan%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span> </span><span class="NLM_article-title">Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">314</span> <span class="NLM_fpage">1274</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1124%2Fjpet.105.086363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15951399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1274-1289&author=L.+E.+Schechterauthor=D.+L.+Smithauthor=S.+Rosenzweig-Lipsonauthor=S.+J.+Sukoffauthor=L.+A.+Dawsonauthor=K.+Marquisauthor=D.+Jonesauthor=M.+Pieslaauthor=T.+Andreeauthor=S.+Nawoschikauthor=J.+A.+Harderauthor=M.+D.+Womackauthor=J.+Buccafuscoauthor=A.+V.+Terryauthor=B.+Hoebelauthor=P.+Radaauthor=M.+Kellyauthor=M.+Abou-Gharbiaauthor=J.+E.+Barrettauthor=W.+Childers&title=Lecozotan+%28SRA-333%29%3A+a+selective+serotonin+1A+receptor+antagonist+that+enhances+the+stimulated+release+of+glutamate+and+acetylcholine+in+the+hippocampus+and+possesses+cognitive-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Lecozotan (SRA-333): A selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span></div><div class="casAuthors">Schechter, L. E.; Smith, D. L.; Rosenzweig-Lipson, S.; Sukoff, S. J.; Dawson, L. A.; Marquis, K.; Jones, D.; Piesla, M.; Andree, T.; Nawoschik, S.; Harder, J. A.; Womack, M. D.; Buccafusco, J.; Terry, A. V.; Hoebel, B.; Rada, P.; Kelly, M.; Abou-Gharbia, M.; Barrett, J. E.; Childers, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent data has suggested that the 5-hydroxytryptamine (5-HT)1A receptor is involved in cognitive processing.  A novel 5-HT1A receptor antagonist, 4-cyano-N-{2R-[4-(2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide HCl (lecozotan), which has been characterized in multiple in vitro and in vivo pharmacol. assays as a drug to treat cognitive dysfunction, is reported.  In vitro binding and intrinsic activity detns. demonstrated that lecozotan is a potent and selective 5-HT1A receptor antagonist.  Using in vivo microdialysis, lecozotan (0.3 mg/kg s.c.) antagonized the decrease in hippocampal extracellular 5-HT induced by a challenge dose (0.3 mg/kg s.c.) of 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) and had no effects alone at doses 10-fold higher.  Lecozotan significantly potentiated the potassium chloride-stimulated release of glutamate and acetylcholine in the dentate gyrus of the hippocampus.  Chronic administration of lecozotan did not induce 5-HT1A receptor tolerance or desensitization in a behavioral model indicative of 5-HT1A receptor function.  In drug discrimination studies, lecozotan (0.01-1 mg/kg i.m.) did not substitute for 8-OH-DPAT and produced a dose-related blockade of the 5-HT1A agonist discriminative stimulus cue.  In aged rhesus monkeys, lecozotan produced a significant improvement in task performance efficiency at an optimal dose (1 mg/kg p.o.).  Learning deficits induced by the glutamatergic antagonist MK-801 [(-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] (assessed by perceptually complex and visual spatial discrimination) and by specific cholinergic lesions of the hippocampus (assessed by visual spatial discrimination) were reversed by lecozotan (2 mg/kg i.m.) in marmosets.  The heterosynaptic nature of the effects of lecozotan imbues this compd. with a novel mechanism of action directed at the biochem. pathologies underlying cognitive loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDog5bWsysrLVg90H21EOLACvtfcHk0lja20NA8tmEmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D&md5=4d07a0db6675ddc2238dcca19a4c68b7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.086363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.086363%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DJ.%2BA.%26aulast%3DWomack%26aufirst%3DM.%2BD.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DHoebel%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DChilders%26aufirst%3DW.%26atitle%3DLecozotan%2520%2528SRA-333%2529%253A%2520a%2520selective%2520serotonin%25201A%2520receptor%2520antagonist%2520that%2520enhances%2520the%2520stimulated%2520release%2520of%2520glutamate%2520and%2520acetylcholine%2520in%2520the%2520hippocampus%2520and%2520possesses%2520cognitive-enhancing%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1274%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Yardley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, G. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicksler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A.</span><span> </span><span class="NLM_article-title">2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">33</span> <span class="NLM_fpage">2899</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00172a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2899-2905&author=J.+P.+Yardleyauthor=G.+E.+M.+Husbandsauthor=G.+Stackauthor=J.+Butchauthor=J.+Bickslerauthor=J.+A.+Moyerauthor=E.+A.+Muthauthor=T.+Andreeauthor=H.+Fletcherauthor=M.+N.+G.+Jamesauthor=A.+Sielecki&title=2-Phenyl-2-%281-hydroxycycloalkyl%29ethylamine+derivatives%3A+synthesis+and+antidepressant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm00172a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00172a035%26sid%3Dliteratum%253Aachs%26aulast%3DYardley%26aufirst%3DJ.%2BP.%26aulast%3DHusbands%26aufirst%3DG.%2BE.%2BM.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DButch%26aufirst%3DJ.%26aulast%3DBicksler%26aufirst%3DJ.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%26atitle%3D2-Phenyl-2-%25281-hydroxycycloalkyl%2529ethylamine%2520derivatives%253A%2520synthesis%2520and%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2899%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entsuah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, R.</span><span> </span><span class="NLM_article-title">Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">178</span> <span class="NLM_fpage">234</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1192%2Fbjp.178.3.234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=11230034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A280%3ADC%252BD3M3jsF2nsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2001&pages=234-241&author=M.+E.+Thaseauthor=R.+Entsuahauthor=R.+Rudolph&title=Remission+rates+during+treatment+with+venlafaxine+or+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Thase M E; Entsuah A R; Rudolph R L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-41</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">BACKGROUND:  It had been suggested that the antidepressant venlafaxine, which inhibits reuptake of both serotonin and (at higher doses) noradrenaline, may result in better outcomes than treatment with selective serotonin reuptake inhibitors (SSRIs).  AIMS:  To compare remission rates during treatment with SSRIs or venlafaxine.  METHOD:  Data from eight comparable randomised, double-blind studies of major depressive disorder were pooled to compare remission rates (Hamilton Rating Scale for Depression score < or = 7) during treatment with venlafaxine (n = 851), SSRIs (fluoxetine, paroxetine, fluvoxamine; n = 748) or placebo (four studies; n = 446).  RESULTS:  Remission rates were: venlafaxine, 45% (382/851); SSRIs, 35% (260/748); placebo, 25% (110/446) (P: < 0.001; odds ratio for remission is 1.50 (1.3-1.9), favouring venlafaxine v.  SSRIs).  The difference between venlafaxine and the SSRIs was significant at week 2, whereas the difference between SSRIs and placebo reached significance at week 4.  Results were not dependent on any one study or the definition of remission.  CONCLUSIONS:  Remission rates were significantly higher with venlafaxine than with an SSRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs9tUzV0t0zlMGsG_HTXYFfW6udTcc2eZzvb7mrs4pD7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3jsF2nsA%253D%253D&md5=b3d4837133664af7621f670ed2743eed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1192%2Fbjp.178.3.234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.178.3.234%26sid%3Dliteratum%253Aachs%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DEntsuah%26aufirst%3DR.%26aulast%3DRudolph%26aufirst%3DR.%26atitle%3DRemission%2520rates%2520during%2520treatment%2520with%2520venlafaxine%2520or%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D178%26spage%3D234%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Septien-Velez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitrosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourian, K.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">22</span><span class="NLM_issue">6</span> <span class="NLM_fpage">338</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1097%2FYIC.0b013e3281e2c84b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17917552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A280%3ADC%252BD2srpsFKrsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=338-353&issue=6&author=L.+Septien-Velezauthor=B.+Pitroskyauthor=S.+K.+Padmanabhanauthor=J.-M.+Germainauthor=K.+Tourian&title=A+randomized%2C+double-blind%2C+placebo-controlled+trial+of+desvenlafaxine+succinate+in+the+treatment+of+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder</span></div><div class="casAuthors">Septien-Velez Lucia; Pitrosky Bruno; Padmanabhan Sudharshan Krishna; Germain Jean-Michel; Tourian Karen A</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-47</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The antidepressant efficacy and safety of desvenlafaxine succinate (desvenlafaxine) were evaluated in a phase III, double-blind, placebo-controlled study.  Outpatients with a primary diagnosis of major depressive disorder were treated with fixed once-daily doses of desvenlafaxine 200 or 400 mg for 8 weeks.  The primary efficacy measure was change from baseline on the 17-item Hamilton Rating Scale for Depression.  At the final on-therapy evaluation, adjusted mean change from baseline in 17-item Hamilton Rating Scale for Depression total score was greater for desvenlafaxine 200 and 400 mg/day vs. placebo.  Both desvenlafaxine doses showed greater efficacy than placebo on the secondary efficacy measures, including the Clinical Global Impressions-Improvement scale scores, Montgomery-Asberg Depression Rating Scale scores, CGI-Severity, and 17-item Hamilton Rating Scale for Depression response rate.  Desvenlafaxine 200 mg/day was also significantly better than placebo on remission, Visual Analog Scale-Pain Intensity overall scores, and some Visual Analog Scale-Pain Intensity subscale scores.  Desvenlafaxine 400 mg/day was significantly better than placebo on selected Visual Analog Scale-Pain Intensity subscale scores.  Most adverse events were mild or moderate in severity, and safety assessments revealed few clinically significant changes in vital signs, laboratory tests, and electrocardiogram results.  These data provide support for the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-3qwLgEqxGYNpW7w2tapOfW6udTcc2eZzvb7mrs4pD7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srpsFKrsg%253D%253D&md5=d69928308b3c7a4fb5b0b6721d2737a1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1097%2FYIC.0b013e3281e2c84b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0b013e3281e2c84b%26sid%3Dliteratum%253Aachs%26aulast%3DSeptien-Velez%26aufirst%3DL.%26aulast%3DPitrosky%26aufirst%3DB.%26aulast%3DPadmanabhan%26aufirst%3DS.%2BK.%26aulast%3DGermain%26aufirst%3DJ.-M.%26aulast%3DTourian%26aufirst%3DK.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520desvenlafaxine%2520succinate%2520in%2520the%2520treatment%2520of%2520major%2520depressive%2520disorder%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2007%26volume%3D22%26issue%3D6%26spage%3D338%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span> </span><span class="NLM_article-title">Integrity profiling of high throughput screening hits using LCâMS and related techniques</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">459</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F1386207054867283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=16178805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslOnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=459-466&author=E.+H.+Kernsauthor=L.+Di&title=Integrity+profiling+of+high+throughput+screening+hits+using+LC%E2%88%92MS+and+related+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Integrity profiling of high throughput screening hits using LC-MS and related techniques</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Bourassa, Jim; Gross, Jonathan; Huang, Nelson; Liu, Hanlan; Kleintop, Teresa; Nogle, Lisa; Mallis, Larry; Petucci, Chris; Petusky, Susan; Tischler, Mark; Sabus, Chantel; Sarkahian, Ani; Young, Mairead; Zhang, Mei-yi; Huryn, Donna; McConnell, Oliver; Carter, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrity profiling of HTS hits is valuable for verification of the hit identity and purity.  This provides early discovery researchers with more confident SAR theories.  Methodol. for integrity profiling of HTS hits must be high throughput, consume little material, and selectively provide structure-based data.  Anal. techniques that can be utilized for integrity profiling methods are reviewed for their appropriateness in sample prepn., component sepn., detection, purity quantitation, identity confirmation, and follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-CVqhdtheP7Vg90H21EOLACvtfcHk0liwFZsyT0Z0-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslOnurs%253D&md5=bc75cbcb60b00fd34e14ea3663969826</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1386207054867283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207054867283%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DIntegrity%2520profiling%2520of%2520high%2520throughput%2520screening%2520hits%2520using%2520LC%25E2%2588%2592MS%2520and%2520related%2520techniques%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2005%26volume%3D8%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span> In  <span class="citation_source-book">Integrated Strategies for Drug Discovery Using Mass Spectrometry</span>; <span class="NLM_contrib-group">Lee, M. S.</span>, Ed.; <span class="NLM_publisher-name">Wiley Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">1988</span>; pp  <span class="NLM_fpage">433</span>â <span class="NLM_lpage">458</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=433-458&author=E.+H.+Kerns&author=L.+Diauthor=M.+S.+Lee&title=Integrated+Strategies+for+Drug+Discovery+Using+Mass+Spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26btitle%3DIntegrated%2520Strategies%2520for%2520Drug%2520Discovery%2520Using%2520Mass%2520Spectrometry%26aulast%3DLee%26aufirst%3DM.%2BS.%26pub%3DWiley%2520Interscience%26date%3D1988%26spage%3D433%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span> </span><span class="NLM_article-title">Utility of mass spectrometry for pharmaceutical profiling applications</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">457</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F138920006777697981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=16787155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVajtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=457-466&author=E.+H.+Kernsauthor=L.+Di&title=Utility+of+mass+spectrometry+for+pharmaceutical+profiling+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of mass spectrometry for pharmaceutical profiling applications</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">457-466</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  MS has great utility for pharmaceutical profiling, the measurement of physicochem. and metabolic properties that are crucial to the discovery and development of new drug candidates.  An evaluation of the capabilities of MS to improve the speed, specificity, sensitivity and cost per compd. of method in development indicates when MS technologies have utility compared to other anal. techniques.  MS was used successfully for methods that profile the crit. properties: permeability, lipophilicity, plasma and soln. stability, soly., plasma protein binding and integrity.  In general, MS has utility in these methods using anal. strategies involving unique MS technologies (e.g., parallel multiplexed interfaces, trap-and-elute), orthogonal detection to UV, high sensitivity for low LOQs, low concn. studies, highly specific MS/MS SRM, combinatorial anal., use of internal stds., providing initial structural data in addn. to quant. and facile integration with HPLC autosamplers and other hardware that allow enhanced online expts.  Ultimately, it is important to evaluate the appropriateness of any technique that is being considered for use in a method, to insure that it best meets all of the criteria for the organization's needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkScTOipViG7Vg90H21EOLACvtfcHk0liwFZsyT0Z0-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVajtLs%253D&md5=30a83a479880d9162f5519ef459d82ef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F138920006777697981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006777697981%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DUtility%2520of%2520mass%2520spectrometry%2520for%2520pharmaceutical%2520profiling%2520applications%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D457%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">High throughput screening of metabolic stability in drug discovery</span> <span class="citation_source-journal">Am. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">28</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=28-32&author=L.+Diauthor=E.+H.+Kerns&title=High+throughput+screening+of+metabolic+stability+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DHigh%2520throughput%2520screening%2520of%2520metabolic%2520stability%2520in%2520drug%2520discovery%26jtitle%3DAm.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D28%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, P.</span><span> </span><span class="NLM_article-title">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">93</span> <span class="NLM_fpage">1440</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1002%2Fjps.20075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15124203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12iu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1440-1453&author=E.+H.+Kernsauthor=L.+Diauthor=S.+Petuskyauthor=M.+Farrisauthor=R.+Leyauthor=P.+Jupp&title=Combined+application+of+parallel+artificial+membrane+permeability+assay+and+Caco-2+permeability+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Petusky, Susan; Farris, Michele; Ley, Rob; Jupp, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1440-1453</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Data from permeability profiling using the parallel artificial membrane permeability assay (PAMPA) and cell monolayer (Caco-2 and MDR1-MDCKII) methods were compared for two published compd. sets and one inhouse set.  A majority of compds. in each set correlated (R2 = 0.76-0.92), indicating the predominance of passive diffusion in the permeation of these compds.  Compds. that did not correlate grouped into two subsets.  One subset had higher PAMPA permeability than cell monolayer permeability and consisted of compds. that are subject to secretory mechanisms: efflux or reduced passive diffusion of bases under Caco-2 when run under a pH gradient.  The other subset had higher cell monolayer permeability than PAMPA permeability and consisted of compds. that are subject to absorptive mechanisms: paracellular, active transport, or increased passive diffusion of acids under Caco-2 when run under a pH gradient.  Given the characteristics of the two methods, these studies suggest how PAMPA and Caco-2 can be synergistically applied for efficient and rapid investigation of permeation mechanisms in drug discovery.  During early discovery, all compds. can be rapidly screened using PAMPA at low pH and neutral pH to assess passive diffusion permeability to indicate potential for gastrointestinal and cell assay permeation.  During intermediate discovery, selected compds. can be addnl. assayed by apical-to-basolateral Caco-2, which, in combination with PAMPA data, indicates susceptibility to addnl. permeation mechanisms (secretory and absorptive).  During mid-to-late discovery, selected candidates can be examd. in detail via multiple directional Caco-2 expts. and with transporter inhibitors for complete characterization of permeation mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1M-v5UG2RLVg90H21EOLACvtfcHk0liwFZsyT0Z0-w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12iu7w%253D&md5=428596e93f30763e94ced9341d23a02e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.20075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20075%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DPetusky%26aufirst%3DS.%26aulast%3DFarris%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DR.%26aulast%3DJupp%26aufirst%3DP.%26atitle%3DCombined%2520application%2520of%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520and%2520Caco-2%2520permeability%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A.</span><span> </span><span class="NLM_article-title">Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatograpy-tandem mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">359</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1016%2FS0731-7085%2803%2900523-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15013150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=359-368&author=M.+Y.+Zhangauthor=E.+H.+Kernsauthor=O.+McConnellauthor=J.+Sonnenberg-Reinesauthor=M.+M.+Zaleskaauthor=J.+S.+Jacobsenauthor=J.+Buteraauthor=A.+Kreft&title=Brain+and+plasma+exposure+profiling+in+early+drug+discovery+using+cassette+administration+and+fast+liquid+chromatograpy-tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Zhang, Mei-Yi; Kerns, Edward; McConnell, Oliver; Sonnenberg-Reines, June; Zaleska, Margaret M.; Jacobsen, J. Steven; Butera, John; Kreft, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A method using reverse phase liq. chromatog.-tandem mass spectrometry and cassette administration was developed for in vivo brain and plasma exposure profiling to assist early CNS drug discovery programs.  Three to 4 compds. were grouped in cassettes for dosing and anal.  Compds. in the cassettes were selected to minimize possible anal. interference from each other, as well as from their potential metabolites.  In order to improve the confidence of cassette administration, an analog of the study compds., with well-established brain penetration data, was included in each cassette as a "biol. internal std.".  Compds. were administered to rats by i.p. injection and extd. from plasma or brain homogenate by simple protein pptn.  Fast chromatog. sepn. was achieved by a short narrow-bore column at a flow rate of 1.0 mL/min with a fast gradient.  The brain penetration of the compds. was evaluated by comparing their Cmax and AUC values in brain and plasma.  This approach rapidly provided early brain penetration and plasma exposure information, thus making more of this data available to teams.  Comparing the brain exposures to the EC50 values (i.e. in vitro potency) of series compds. in the same discovery program provided another dimension of information to select lead compds. for future in vivo assessment.  The method described here was used for providing early brain penetration information in several CNS exploratory and discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3LoIREMMFFrVg90H21EOLACvtfcHk0li483ZNwbC8Gg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaruw%253D%253D&md5=09adf6630a34e77b9f26b9ab0928a201</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2803%2900523-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252803%252900523-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DMcConnell%26aufirst%3DO.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26aulast%3DButera%26aufirst%3DJ.%26aulast%3DKreft%26aufirst%3DA.%26atitle%3DBrain%2520and%2520plasma%2520exposure%2520profiling%2520in%2520early%2520drug%2520discovery%2520using%2520cassette%2520administration%2520and%2520fast%2520liquid%2520chromatograpy-tandem%2520mass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D34%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Techesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grams, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, K.</span><span> </span><span class="NLM_article-title">Structural properties of matrix metalloproteinases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1007%2Fs000180050320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=10357232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlWlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=639&author=W.+Bodeauthor=C.+Fernandez-Catalanauthor=H.+Techescheauthor=F.+Gramsauthor=H.+Nagageauthor=K.+Maskos&title=Structural+properties+of+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural properties of matrix metalloproteinases</span></div><div class="casAuthors">Bode, W.; Fernandez-Catalan, C.; Tschesche, H.; Grams, F.; Nagase, H.; Maskos, K.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-652</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review is given with 89 refs. on the 3-dimensional structures and activity of MMPs.  Matrix metalloproteinases (MMPs) are involved in extracellular matrix degrdn.  Their proteolytic activity must be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs).  Disruption of this balance results in serious diseases such as arthritis, tumor growth and metastasis.  Knowledge of the tertiary structures of the proteins involved is crucial for understanding their functional properties and interference with assocd. dysfunctions.  Within the last few years, several 3-dimensional MMP and MMP-TIMP structures became available, showing the domain organization, polypeptide fold and main specificity determinants.  Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6phf288RNY7Vg90H21EOLACvtfcHk0li483ZNwbC8Gg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlWlurw%253D&md5=aaafe8566dae1cbe0652ca5256f6ddd0</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs000180050320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050320%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DTechesche%26aufirst%3DH.%26aulast%3DGrams%26aufirst%3DF.%26aulast%3DNagage%26aufirst%3DH.%26aulast%3DMaskos%26aufirst%3DK.%26atitle%3DStructural%2520properties%2520of%2520matrix%2520metalloproteinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D1999%26volume%3D55%26spage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Maskos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourenkov, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H. R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerretti, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Catalytic Domain of Human Tumor Necrosis Factor-Î± Converting Enzyme,</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.,</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">95</span> <span class="NLM_fpage">3408</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1073%2Fpnas.95.7.3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=9520379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1cXitlGqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3408-3412&author=K.+Maskosauthor=C.+Fernandez-Catalanauthor=R.+Huberauthor=G.+P.+Bourenkovauthor=H.+Bartunikauthor=G.+A.+Ellestadauthor=P.+Reddyauthor=M.+F.+Wolsonauthor=C.+T.+Rauchauthor=B.+J.+Castnerauthor=R.+Davisauthor=H.+R.+G.+Clarkeauthor=M.+Petersenauthor=J.+N.+Fitznerauthor=D.+P.+Cerrettiauthor=C.+J.+Marchauthor=R.+J.+Paxtonauthor=R.+A+Blackauthor=W.+Bode&title=Crystal+Structure+of+the+Catalytic+Domain+of+Human+Tumor+Necrosis+Factor-%CE%B1+Converting+Enzyme%2C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic domain of human tumor necrosis factor-Î±-converting enzyme</span></div><div class="casAuthors">Maskos, Klaus; Fernandez-Catalan, Carlos; Huber, Robert; Bourenkov, Gleb P.; Bartunik, Hans; Ellestad, George A.; Reddy, Pranitha; Wolfson, Martin F.; Rauch, Charles T.; Castner, Beverly J.; Davis, Raymond; Clarke, Howard R. G.; Petersen, Melissa; Fitzner, Jeffrey N.; Cerretti, Douglas Pat; March, Carl J.; Paxton, Raymond J.; Black, Roy A.; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3408-3412</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor-Î± (TNFÎ±) is a cytokine that induces protective inflammatory reactions and kills tumor cells but also causes severe damage when produced in excess, as in rheumatoid arthritis and septic shock.  Sol. TNFÎ± is released from its membrane-bound precursor by a membrane-anchored proteinase, recently identified as a multidomain metalloproteinase called TNF-Î±-converting enzyme or TACE.  We have cocrystd. the catalytic domain of TACE with a hydroxamic acid inhibitor and have solved its 2.0 Ã crystal structure.  This structure reveals a polypeptide fold and a catalytic zinc environment resembling that of the snake venom metalloproteinases, identifying TACE as a member of the adamalysin/ADAM family.  However, a no. of large insertion loops generate unique surface features.  The pro-TNFÎ± cleavage site fits to the active site of TACE but seems also to be detd. by its position relative to the base of the compact trimeric TNFÎ± cone.  The active-site cleft of TACE shares properties with the matrix metalloproteinases but exhibits unique features such as a deep S3' pocket merging with the S1' specificity pocket below the surface.  The structure thus opens a different approach toward the design of specific synthetic TACE inhibitors, which could act as effective therapeutic agents in vivo to modulate TNFÎ±-induced pathophysiol. effects, and might also help to control related shedding processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQkmDbGcCls7Vg90H21EOLACvtfcHk0li483ZNwbC8Gg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlGqu7g%253D&md5=57628757fd53cc972a6fe701e549495f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3408%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBourenkov%26aufirst%3DG.%2BP.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DWolson%26aufirst%3DM.%2BF.%26aulast%3DRauch%26aufirst%3DC.%2BT.%26aulast%3DCastner%26aufirst%3DB.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DH.%2BR.%2BG.%26aulast%3DPetersen%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DJ.%2BN.%26aulast%3DCerretti%26aufirst%3DD.%2BP.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA%26aulast%3DBode%26aufirst%3DW.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520Human%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Converting%2520Enzyme%252C%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%26date%3D1998%26volume%3D95%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE Inhibitors. Part 1. SAR of the Acyclic Sulfonamide Hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.,</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2798</span> <span class="NLM_lpage">2803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2798-2803&author=J.+I.+Levinauthor=J.+M.+Chenauthor=K.+Cheungauthor=D.+Coleauthor=C.+Cragoauthor=E.+Delos+Santosauthor=X.+Duauthor=G.+Khafizovaauthor=G.+MacEwanauthor=C.+Niuauthor=E.+J.+Salaskiauthor=A.+Zaskauthor=T.+Cummonsauthor=A.+Sungauthor=J.+Xuauthor=Y.+Zhangauthor=W.+Xuauthor=S.+Ayral-Kaloustianauthor=G.+Jinauthor=R.+Cowlingauthor=D.+Baroneauthor=K.+M.+Mohlerauthor=R.+A.+Blackauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+Inhibitors.+Part+1.+SAR+of+the+Acyclic+Sulfonamide+Hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCrago%26aufirst%3DC.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSalaski%26aufirst%3DE.%2BJ.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSung%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DMohler%26aufirst%3DK.%2BM.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520Inhibitors.%2520Part%25201.%2520SAR%2520of%2520the%2520Acyclic%2520Sulfonamide%2520Hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%252C%26date%3D2003%26volume%3D13%26spage%3D2798%26epage%3D2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE Inhibitors. Part 3. Thiomorpholine Sulfonamide Hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.,</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1605</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1605-1609&author=J.+I.+Levinauthor=J.+M.+Chenauthor=L.+M.+Laaksoauthor=M.+Duauthor=J.+Schmidauthor=W.+Xuauthor=T.+Cummonsauthor=J.+Xuauthor=G.+Jinauthor=D.+Baroneauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+Inhibitors.+Part+3.+Thiomorpholine+Sulfonamide+Hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DLaakso%26aufirst%3DL.%2BM.%26aulast%3DDu%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520Inhibitors.%2520Part%25203.%2520Thiomorpholine%2520Sulfonamide%2520Hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%252C%26date%3D2006%26volume%3D16%26spage%3D1605%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Newman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">70</span> <span class="NLM_fpage">461</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0lgGrElwcULc_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Koehn, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">The evolving role of natural products in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">206</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnrd1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15729362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-220&author=F.+E.+Koehnauthor=G.+T.+Carter&title=The+evolving+role+of+natural+products+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The evolving role of natural products in drug discovery</span></div><div class="casAuthors">Koehn, Frank E.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-220</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their derivs. have historically been invaluable as a source of therapeutic agents.  However, in the past decade, research into natural products in the pharmaceutical industry has declined, owing to issues such as the lack of compatibility of traditional natural-product ext. libraries with high-throughput screening.  However, as discussed in this review, recent technol. advances that help to address these issues, coupled with unrealized expectations from current lead-generation strategies, have led to a renewed interest in natural products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRGIXVxX38LVg90H21EOLACvtfcHk0lgGrElwcULc_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D&md5=ce80052abaa76430220ee5981138053e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1657%26sid%3Dliteratum%253Aachs%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DThe%2520evolving%2520role%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Kanafani, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Daptomycin: a rapidly bactericidal lipopeptide for the treatment of gram-positive infections</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">177</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1586%2F14787210.5.2.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17402833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=177-184&author=Z.+A.+Kanafaniauthor=G.+R.+Corey&title=Daptomycin%3A+a+rapidly+bactericidal+lipopeptide+for+the+treatment+of+gram-positive+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections</span></div><div class="casAuthors">Kanafani, Zeina A.; Corey, G. Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Antimicrobial resistance among Gram-pos. organisms continues to increase and has reached epidemic proportions in a no. of countries and within medical centers worldwide.  Daptomycin is a new lipopeptide antibiotic with rapid bactericidal activity against Staphylococcus aureus.  It is also active against coagulase-neg. staphylococci, enterococci and streptococci.  It exerts its effect through cell membrane disruption that results in dissipation of the membrane potential.  Daptomycin exhibits a prolonged postantibiotic effect and is well tolerated.  In Phase III clin. trials, daptomycin was found to be similar in efficacy to std. therapy in complicated skin and skin structure infections.  More recently, it was approved for the treatment of S. aureus bacteremia and right-sided endocarditis.  Daptomycin is not indicated for pulmonary infections.  Preliminary data suggest that daptomycin may be effective in urinary tract, bone and joint infections.  However, randomized clin. trials are needed to confirm these findings.  Daptomycin is an effective antimicrobial agent for the treatment of various serious Gram-pos. infections, esp. those caused by methicillin-resistant S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cJNFOvyjX7Vg90H21EOLACvtfcHk0lgGrElwcULc_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ktLs%253D&md5=bd7b8c5b11acd9f1cecde9a66893fb97</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1586%2F14787210.5.2.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.5.2.177%26sid%3Dliteratum%253Aachs%26aulast%3DKanafani%26aufirst%3DZ.%2BA.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DDaptomycin%253A%2520a%2520rapidly%2520bactericidal%2520lipopeptide%2520for%2520the%2520treatment%2520of%2520gram-positive%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2007%26volume%3D5%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Sehgal, S. N.</span><span> </span><span class="NLM_article-title">Sirolimus: Its Discovery, Biological Properties and Mechanism of Action</span> <span class="citation_source-journal">Transplantation Proc.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">35</span> <span class="NLM_fpage">7S</span> <span class="NLM_lpage">14S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=7S-14S&author=S.+N.+Sehgal&title=Sirolimus%3A+Its+Discovery%2C+Biological+Properties+and+Mechanism+of+Action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSehgal%26aufirst%3DS.%2BN.%26atitle%3DSirolimus%253A%2520Its%2520Discovery%252C%2520Biological%2520Properties%2520and%2520Mechanism%2520of%2520Action%26jtitle%3DTransplantation%2520Proc.%26date%3D2003%26volume%3D35%26spage%3D7S%26epage%3D14S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Structure of the FKBP12ârapamycin complex interacting with the binding domain of human FRAP</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">273</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12%E2%88%92rapamycin+complex+interacting+with+the+binding+domain+of+human+FRAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%2520complex%2520interacting%2520with%2520the%2520binding%2520domain%2520of%2520human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D239%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation C-42 Hydroxyesters of Rapamycin: The Identification of CCI-779</span> <span class="citation_source-journal">Clinical Cancer Res.,</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">3749S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=3749S&author=J.+S.+Skotnickiauthor=C.+L.+Leoneauthor=A.+L.+Smithauthor=Y.+L.+Palmerauthor=K.+Yuauthor=C.+M.+Discafaniauthor=J.+J.+Gibbonsauthor=P.+Frostauthor=M.+A.+Abou-Gharbia&title=Design%2C+Synthesis+and+Biological+Evaluation+C-42+Hydroxyesters+of+Rapamycin%3A+The+Identification+of+CCI-779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26aulast%3DLeone%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DPalmer%26aufirst%3DY.%2BL.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520C-42%2520Hydroxyesters%2520of%2520Rapamycin%253A%2520The%2520Identification%2520of%2520CCI-779%26jtitle%3DClinical%2520Cancer%2520Res.%252C%26date%3D2001%26volume%3D7%26spage%3D3749S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of C-42 hydroxyesters of rapamycin: the identification of CCI-779</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">659</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1358%2Fdot.2007.43.10.1148059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVCm" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=659-669&author=W.+W.+Maauthor=A.+Jimeno&title=Design%2C+synthesis+and+biological+evaluation+of+C-42+hydroxyesters+of+rapamycin%3A+the+identification+of+CCI-779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Temsirolimus</span></div><div class="casAuthors">Ma, Wen W.; Jimeno, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">1699-3993</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Temsirolimus (CCI-779), a small mol. inhibitor of mTOR protein, is a water-sol. synthetic rapamycin ester that has been developed in both oral and i.v. (i.v.) formulations.  PI3k/Akt/mTOR pathway activation is implicated in the pathogenesis of many cancers.  Inhibition of mTOR protein abrogates pathway-mediated cellular transcription and translation, leading to cell cycle arrest, antiangiogenesis and apoptosis.  The drug has significant in vitro antitumor effect against a no. of cancer cell lines and has demonstrated in vivo cytostatic activity in xenograft models.  Flat dosing of 25 mg, 75 mg and 250 mg i.v. weekly were selected for tumor-specific phase I trials.  Biol. activity was obsd. at all these doses.  However, the frequency and intensity of the toxicities increased at higher doses and more high-dose patients had to reduce the dose or discontinue the drug.  Notable temsirolimus-related toxicities include rash, mucostomatitis, diarrhea, hyperlipidemia, hyperglycemia and thrombocytopenia.  Temsirolimus is farther along in clin. development than any other mTOR inhibitor in its class and has demonstrated significant activity in patients with poor-risk clear-cell renal cell carcinoma.  Patients receiving temsirolimus alone achieved longer survival than those receiving interferon alone or temsirolimus plus interferon in a randomized phase III trial.  Predictive biomarkers for clin. efficacy are undetd. and remain under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWPz_d4Lo4kbVg90H21EOLACvtfcHk0liJz6p8kvXXFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVCm&md5=af7659bf35464f266b7f8ec1e9f6c95b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1358%2Fdot.2007.43.10.1148059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2007.43.10.1148059%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DJimeno%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520C-42%2520hydroxyesters%2520of%2520rapamycin%253A%2520the%2520identification%2520of%2520CCI-779%26jtitle%3DDrugs%2520Today%26date%3D2007%26volume%3D43%26spage%3D659%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Immunophilins and the nervous system</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_fpage">32</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=32-37&author=S.+H.+Snyderauthor=D.+M.+Sabatini&title=Immunophilins+and+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DImmunophilins%2520and%2520the%2520nervous%2520system%26jtitle%3DNature%2520Med.%26date%3D1995%26spage%3D32%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Sharkey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, S. P.</span><span> </span><span class="NLM_article-title">Immunophilins mediate the neuroprotective effects of FK-506 in focal cerebral ischemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">371</span> <span class="NLM_fpage">336</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=1994&pages=336-339&author=J.+Sharkeyauthor=S.+P.+Butcher&title=Immunophilins+mediate+the+neuroprotective+effects+of+FK-506+in+focal+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DButcher%26aufirst%3DS.%2BP.%26atitle%3DImmunophilins%2520mediate%2520the%2520neuroprotective%2520effects%2520of%2520FK-506%2520in%2520focal%2520cerebral%2520ischemia%26jtitle%3DNature%26date%3D1994%26volume%3D371%26spage%3D336%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Steiner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hestu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Neurotrophic actions of nonimmunosuppressive analogs of immunosuppressive drugs FK-506, rapamycin and cyclosporin</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">421</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnm0497-421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=9095176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Cktbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=421-428&author=J.+P.+Steinerauthor=M.+A.+Connollyauthor=H.+L.+Valentineauthor=G.+S.+Hamiltonauthor=T.+M.+Dawsonauthor=L.+Hestuauthor=S.+H.+Snyder&title=Neurotrophic+actions+of+nonimmunosuppressive+analogs+of+immunosuppressive+drugs+FK-506%2C+rapamycin+and+cyclosporin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophic actions of non-immunosuppressive analogs of immunosuppressive drugs FK506, rapamycin and cyclosporin A</span></div><div class="casAuthors">Steiner, Joseph P.; Connolly, Maureen A.; Valentine, heather L.; Hamilton, Gregory S.; Dawson, Ted M.; Hester, Lynda; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-428</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">We show that the non-immunosuppressive analogs of the immunosuppressive drugs FK506, rapamycin and cyclosporin A promote neurite outgrowth both in PC12 cells and sensory neuronal cultures of dorsal root ganglia with potencies resembling their immunosuppressive homologues.  Neurotrophic potencies of the immunophilin ligands resemble their potencies in binding to and inhibiting the rotamase activity of FKBP-12 or cyclophilin.  Since nonimmunosuppressive immunophilin ligands, which are devoid of calcineurin inhibitory activity, are equally neurotrophic, inhibition of calcineurin activity is not the mediator of the neurotrophic effects.  The immunophilin ligands are neurotrophic in intact animals.  FK506 and L-685,818 (the C18-hydroxy, C21-Et deriv. of FK506) treatment of rats with crushed sciatic nerves enhances both functional and morphol. recovery.  The striking potency of these agents, their bioavailability and the dissocn. of neurotrophic from immunosuppressant actions argue for their therapeutic relevance in the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohOa5nM7tRtbVg90H21EOLACvtfcHk0liJz6p8kvXXFg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Cktbo%253D&md5=5490b2739cf699ec8b870c090c35fb5a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnm0497-421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0497-421%26sid%3Dliteratum%253Aachs%26aulast%3DSteiner%26aufirst%3DJ.%2BP.%26aulast%3DConnolly%26aufirst%3DM.%2BA.%26aulast%3DValentine%26aufirst%3DH.%2BL.%26aulast%3DHamilton%26aufirst%3DG.%2BS.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHestu%26aufirst%3DL.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DNeurotrophic%2520actions%2520of%2520nonimmunosuppressive%2520analogs%2520of%2520immunosuppressive%2520drugs%2520FK-506%252C%2520rapamycin%2520and%2520cyclosporin%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Gold, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Densmore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzuk, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, H. S. J.</span><span> </span><span class="NLM_article-title">Immunophilin FK506-binding protein FKBP-52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">289</span> <span class="NLM_fpage">1202</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=10336507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGgu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1202-1210&author=B.+G.+Goldauthor=V.+Densmoreauthor=W.+Shouauthor=M.+M.+Matzukauthor=H.+S.+J.+Gordon&title=Immunophilin+FK506-binding+protein+FKBP-52+%28not+FK506-binding+protein+12%29+mediates+the+neurotrophic+action+of+FK506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506</span></div><div class="casAuthors">Gold, Bruce G.; Densmore, Valerie; Shou, Weinian; Matzuk, Martin M.; Gordon, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1202-1210</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The neurotrophic property of the immunosuppressant drug FK506 (tacrolimus) is believed to depend on the 12-kDa FK506-binding protein (FKBP-12).  Here, we show that FK506 maintains its neurotrophic activity in primary hippocampal cell cultures from FKBP-12 knockout mice.  In human neuroblastoma SH-SY5Y cells, the neurotrophic action of FK506 (10 pM to 10 nM) is completely prevented by the addn. of a monoclonal antibody (50-100 nM) to the immunophilin FKBP-52 (also known as FKBP-59 or heat shock protein 56), a component of mature steroid receptor complexes.  By itself, the FKBP-52 antibody is also neurotrophic.  The neurotrophic activity of dexamethasone (50 nM) is potentiated by FK506, whereas that of Î²-estradiol (50 nM) is not altered, suggesting a common mechanisms of action.  Geldanamycin (which disrupts mature steroid receptor complexes) is also neurotrophic (0.1-10 nM), whereas it reduces the neurotrophic activity of FK506 and steroid hormones (dexamethasone and Î²-estradiol).  Conversely, 20 mM molybdate (which prevents the disruption of mature steroid receptor complexes) decreases the neurotrophic activity of FK506, FKBP-52 antibody, dexamethasone, and Î²-estradiol.  In rats, FK506 (10 mg/kg s.c.) augments the regenerative response of regenerating motor and sensory neurons to nerve injury as shown by its ability to increase the axotomy-induced induction of c-jun expression.  A model is proposed to account for the neurotrophic action of both neuroimmunophilin ligands (FK506) and steroid hormones.  Components of steroid receptor complexes represent novel targets for the rational design of new neurotrophic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlLoqLj-LqdLVg90H21EOLACvtfcHk0lhbHSnr_0oY6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGgu7Y%253D&md5=1b7762e53fd5af081ddc4ab51276bf9c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DB.%2BG.%26aulast%3DDensmore%26aufirst%3DV.%26aulast%3DShou%26aufirst%3DW.%26aulast%3DMatzuk%26aufirst%3DM.%2BM.%26aulast%3DGordon%26aufirst%3DH.%2BS.%2BJ.%26atitle%3DImmunophilin%2520FK506-binding%2520protein%2520FKBP-52%2520%2528not%2520FK506-binding%2520protein%252012%2529%2520mediates%2520the%2520neurotrophic%2520action%2520of%2520FK506%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D1202%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Lyons, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Immunosuppressant FK-506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">91</span> <span class="NLM_fpage">3191</span> <span class="NLM_lpage">3195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3191-3195&author=W.+E.+Lyonsauthor=E.+B.+Georgeauthor=T.+M.+Dawsonauthor=J.+P.+Steinerauthor=S.+H.+Snyder&title=Immunosuppressant+FK-506+promotes+neurite+outgrowth+in+cultures+of+PC12+cells+and+sensory+ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DW.%2BE.%26aulast%3DGeorge%26aufirst%3DE.%2BB.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSteiner%26aufirst%3DJ.%2BP.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DImmunosuppressant%2520FK-506%2520promotes%2520neurite%2520outgrowth%2520in%2520cultures%2520of%2520PC12%2520cells%2520and%2520sensory%2520ganglia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D3191%26epage%3D3195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Ruan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crozier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehn, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, E. I.</span><span> </span><span class="NLM_article-title">Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">105</span><span class="NLM_issue">1</span> <span class="NLM_fpage">33</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=33-38&issue=1&author=B.+Ruanauthor=K.+Pongauthor=F.+Jowauthor=M.+Bowlbyauthor=R.+A.+Crozierauthor=D.+Liuauthor=M.+M.+Zaleskaauthor=A.+Woodauthor=P.+H.+Reinhartauthor=R.+Magoldaauthor=J.+Skotnickiauthor=M.+N.+Pangalosauthor=F.+E.+Koehnauthor=G.+T.+Carterauthor=M.+Abou-Gharbiaauthor=E.+I.+Graziani&title=Binding+of+rapamycin+analogs+to+calcium+channels+and+FKBP52+contributes+to+their+neuroprotective+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DB.%26aulast%3DPong%26aufirst%3DK.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DBowlby%26aufirst%3DM.%26aulast%3DCrozier%26aufirst%3DR.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DReinhart%26aufirst%3DP.%2BH.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DGraziani%26aufirst%3DE.%2BI.%26atitle%3DBinding%2520of%2520rapamycin%2520analogs%2520to%2520calcium%2520channels%2520and%2520FKBP52%2520contributes%2520to%2520their%2520neuroprotective%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26issue%3D1%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Pong, K.; Graziani, E.; Liang, S.; Liu, D.; Chen, Y.; Gonzales, C.; McIlvain, H. D.; Reinhart, P. H.; Pangalos, M. N.; Ruan, B.; Skotnicki, J.; Koehn, F.; Carter, G.; Magolda, R.; Abou-Gharbia, M.; Zaleska, M. M.; Wood, A.</span><span> </span><span class="NLM_article-title">ILS-920, a Novel, Nonimmunosuppressive Rapamycin Analog, Stimulates Neuronal Survival and Outgrowth and Promotes Cellular and Functional Recovery following Cerebral Ischemia</span>. Presented at the 22th Annual Meeting of the Society for Neuroscience, <span class="NLM_year">2007</span>, San Diego, CA; Poster 598.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Pong&author=E.+Graziani&author=S.+Liang&author=D.+Liu&author=Y.+Chen&author=C.+Gonzales&author=H.+D.+McIlvain&author=P.+H.+Reinhart&author=M.+N.+Pangalos&author=B.+Ruan&author=J.+Skotnicki&author=F.+Koehn&author=G.+Carter&author=R.+Magolda&author=M.+Abou-Gharbia&author=M.+M.+Zaleska&author=A.+Wood&title=ILS-920%2C+a+Novel%2C+Nonimmunosuppressive+Rapamycin+Analog%2C+Stimulates+Neuronal+Survival+and+Outgrowth+and+Promotes+Cellular+and+Functional+Recovery+following+Cerebral+Ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPong%26aufirst%3DK.%26atitle%3DILS-920%252C%2520a%2520Novel%252C%2520Nonimmunosuppressive%2520Rapamycin%2520Analog%252C%2520Stimulates%2520Neuronal%2520Survival%2520and%2520Outgrowth%2520and%2520Promotes%2520Cellular%2520and%2520Functional%2520Recovery%2520following%2520Cerebral%2520Ischemia%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">660</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=W.+Murrayauthor=R.+Carr&title=Fragment-based+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0ljyK_ylWpQBKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DW.%26aulast%3DCarr%26aufirst%3DR.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 22 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Gabriel Castro-FalcÃ³n, Natalie MillÃ¡n-AguiÃ±aga, Catherine Roullier, Paul R. Jensen, <span class="NLM_string-name hlFld-ContribAuthor">Chambers C. Hughes</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrosopyridine Probe To Detect Polyketide Natural Products with Conjugated Alkenes: Discovery of Novodaryamide and Nocarditriene. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (11)
                                     , 3097-3106. <a href="https://doi.org/10.1021/acschembio.8b00598" title="DOI URL">https://doi.org/10.1021/acschembio.8b00598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.8b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.8b00598%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DNitrosopyridine%252BProbe%252BTo%252BDetect%252BPolyketide%252BNatural%252BProducts%252Bwith%252BConjugated%252BAlkenes%25253A%252BDiscovery%252Bof%252BNovodaryamide%252Band%252BNocarditriene%26aulast%3DCastro-Falc%25C3%25B3n%26aufirst%3DGabriel%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27062018%26date%3D01102018%26date%3D26102018%26date%3D01102018%26volume%3D13%26issue%3D11%26spage%3D3097%26epage%3D3106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Takumi Abe, Haruka Shimizu, Shiori Takada, Takahiro Tanaka, Mai Yoshikawa, <span class="NLM_string-name hlFld-ContribAuthor">Koji Yamada</span>. </span><span class="cited-content_cbyCitation_article-title">Double âOpen and Shutâ Transformation of Î³-Carbolines Triggered by Ammonium Salts: One-Pot Synthesis of Multiheterocyclic Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (6)
                                     , 1589-1592. <a href="https://doi.org/10.1021/acs.orglett.8b00332" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b00332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b00332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b00332%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DDouble%252B%2525E2%252580%25259COpen%252Band%252BShut%2525E2%252580%25259D%252BTransformation%252Bof%252B%2525CE%2525B3-Carbolines%252BTriggered%252Bby%252BAmmonium%252BSalts%25253A%252BOne-Pot%252BSynthesis%252Bof%252BMultiheterocyclic%252BCompounds%26aulast%3DAbe%26aufirst%3DTakumi%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30012018%26date%3D28022018%26volume%3D20%26issue%3D6%26spage%3D1589%26epage%3D1592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melanie L.  Aprahamian</span>, <span class="hlFld-ContribAuthor ">Svetlana B.  Tikunova</span>, <span class="hlFld-ContribAuthor ">Morgan V.  Price</span>, <span class="hlFld-ContribAuthor ">Andres F.  Cuesta</span>, <span class="hlFld-ContribAuthor ">Jonathan P.  Davis</span>, and <span class="hlFld-ContribAuthor ">Steffen  Lindert</span>  . </span><span class="cited-content_cbyCitation_article-title">Successful Identification of Cardiac Troponin Calcium Sensitizers Using a Combination of Virtual Screening and ROC Analysis of Known Troponin C Binders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (12)
                                     , 3056-3069. <a href="https://doi.org/10.1021/acs.jcim.7b00536" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00536</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00536%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DSuccessful%252BIdentification%252Bof%252BCardiac%252BTroponin%252BCalcium%252BSensitizers%252BUsing%252Ba%252BCombination%252Bof%252BVirtual%252BScreening%252Band%252BROC%252BAnalysis%252Bof%252BKnown%252BTroponin%252BC%252BBinders%26aulast%3DAprahamian%26aufirst%3DMelanie%2BL.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07092017%26date%3D16112017%26date%3D26122017%26volume%3D57%26issue%3D12%26spage%3D3056%26epage%3D3069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magid  Abou-Gharbia</span> and <span class="hlFld-ContribAuthor ">Wayne E.  Childers</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Innovative Therapeutics: Todayâs Realities and Tomorrowâs Vision. 2. Pharmaâs Challenges and Their Commitment to Innovation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5525-5553. <a href="https://doi.org/10.1021/jm401564r" title="DOI URL">https://doi.org/10.1021/jm401564r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401564r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401564r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BInnovative%252BTherapeutics%25253A%252BToday%2525E2%252580%252599s%252BRealities%252Band%252BTomorrow%2525E2%252580%252599s%252BVision.%252B2.%252BPharma%2525E2%252580%252599s%252BChallenges%252Band%252BTheir%252BCommitment%252Bto%252BInnovation%26aulast%3DAbou-Gharbia%26aufirst%3DMagid%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D07102013%26date%3D07022014%26date%3D10072014%26date%3D15012014%26volume%3D57%26issue%3D13%26spage%3D5525%26epage%3D5553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukas  Wanka</span>, <span class="hlFld-ContribAuthor ">Khalid  Iqbal</span>, and <span class="hlFld-ContribAuthor ">Peter R.  Schreiner</span>  . </span><span class="cited-content_cbyCitation_article-title">The Lipophilic Bullet Hits the Targets: Medicinal Chemistry of Adamantane Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2013,</strong> <em>113 </em>
                                    (5)
                                     , 3516-3604. <a href="https://doi.org/10.1021/cr100264t" title="DOI URL">https://doi.org/10.1021/cr100264t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr100264t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr100264t%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DThe%252BLipophilic%252BBullet%252BHits%252Bthe%252BTargets%25253A%252BMedicinal%252BChemistry%252Bof%252BAdamantane%252BDerivatives%26aulast%3DWanka%26aufirst%3DLukas%26date%3D2013%26date%3D2013%26date%3D2010%26date%3D16082010%26date%3D25022013%26date%3D08052013%26volume%3D113%26issue%3D5%26spage%3D3516%26epage%3D3604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chunwei  Cheng</span>, <span class="hlFld-ContribAuthor ">Lili  Pan</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Hao  Song</span>, <span class="hlFld-ContribAuthor ">Yong  Qin</span> and <span class="hlFld-ContribAuthor ">Rongshi  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Total Synthesis of (Â±)-Marinopyrrole A and Its Library as Potential Antibiotic and Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2010,</strong> <em>12 </em>
                                    (4)
                                     , 541-547. <a href="https://doi.org/10.1021/cc100052j" title="DOI URL">https://doi.org/10.1021/cc100052j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc100052j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc100052j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DTotal%252BSynthesis%252Bof%252B%252528%2525C2%2525B1%252529-Marinopyrrole%252BA%252Band%252BIts%252BLibrary%252Bas%252BPotential%252BAntibiotic%252Band%252BAnticancer%252BAgents%26aulast%3DCheng%26aufirst%3DChunwei%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D26%252003%25202010%26date%3D29042010%26date%3D12072010%26volume%3D12%26issue%3D4%26spage%3D541%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Velma Ganga  Reddy</span>, <span class="hlFld-ContribAuthor ">T.  Srinivasa Reddy</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Rahul  Kumar</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bhargava</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104765. <a href="https://doi.org/10.1016/j.bioorg.2021.104765" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104765%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCinnamide%252Bderived%252Bpyrimidine-benzimidazole%252Bhybrids%252Bas%252Btubulin%252Binhibitors%25253A%252BSynthesis%25252C%252Bin%252Bsilico%252Band%252Bcell%252Bgrowth%252Binhibition%252Bstudies%26aulast%3DSana%26aufirst%3DSravani%26date%3D2021%26volume%3D110%26spage%3D104765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Dana  Honeycutt</span>, <span class="hlFld-ContribAuthor ">Kimberley M.  Zorn</span>, <span class="hlFld-ContribAuthor ">Alex M.  Clark</span>, <span class="hlFld-ContribAuthor ">Sean  Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Multiobjective Optimization for Drug Discovery and Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-25. <a href="https://doi.org/10.1002/0471266949.bmc122.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc122.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc122.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc122.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAdvances%252Bin%252BMultiobjective%252BOptimization%252Bfor%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DHoneycutt%26aufirst%3DJ.%2BDana%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D25%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanley T.  Crooke</span>, <span class="hlFld-ContribAuthor ">Xue-Hai  Liang</span>, <span class="hlFld-ContribAuthor ">Brenda F.  Baker</span>, <span class="hlFld-ContribAuthor ">Rosanne M.  Crooke</span>. </span><span class="cited-content_cbyCitation_article-title">Antisense technology: A review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100416. <a href="https://doi.org/10.1016/j.jbc.2021.100416" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DAntisense%252Btechnology%25253A%252BA%252Breview%26aulast%3DCrooke%26aufirst%3DStanley%2BT.%26date%3D2021%26volume%3D296%26spage%3D100416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Mignani</span>, <span class="hlFld-ContribAuthor ">Scot  Huber</span>, <span class="hlFld-ContribAuthor ">Helena  TomÃ¡s</span>, <span class="hlFld-ContribAuthor ">JoÃ£o  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Majoral</span>. </span><span class="cited-content_cbyCitation_article-title">Compound high-quality criteria: a new vision to guide the development of drugs, current situation. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (4)
                                     , 573-584. <a href="https://doi.org/10.1016/j.drudis.2016.01.005" title="DOI URL">https://doi.org/10.1016/j.drudis.2016.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2016.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2016.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DCompound%252Bhigh-quality%252Bcriteria%25253A%252Ba%252Bnew%252Bvision%252Bto%252Bguide%252Bthe%252Bdevelopment%252Bof%252Bdrugs%25252C%252Bcurrent%252Bsituation%26aulast%3DMignani%26aufirst%3DSerge%26date%3D2016%26volume%3D21%26issue%3D4%26spage%3D573%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Mignani</span>, <span class="hlFld-ContribAuthor ">Scot  Huber</span>, <span class="hlFld-ContribAuthor ">Helena  TomÃ¡s</span>, <span class="hlFld-ContribAuthor ">JoÃ£o  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Majoral</span>. </span><span class="cited-content_cbyCitation_article-title">Why and how have drug discovery strategies in pharma changed? What are the new mindsets?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2016,</strong> <em>21 </em>
                                    (2)
                                     , 239-249. <a href="https://doi.org/10.1016/j.drudis.2015.09.007" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.09.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.09.007%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DWhy%252Band%252Bhow%252Bhave%252Bdrug%252Bdiscovery%252Bstrategies%252Bin%252Bpharma%252Bchanged%25253F%252BWhat%252Bare%252Bthe%252Bnew%252Bmindsets%25253F%26aulast%3DMignani%26aufirst%3DSerge%26date%3D2016%26volume%3D21%26issue%3D2%26spage%3D239%26epage%3D249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Stocks</span>. </span><span class="cited-content_cbyCitation_article-title">The small molecule drug discovery process â from target selection to candidate selection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 81-126. <a href="https://doi.org/10.1016/B978-0-12-397176-0.00003-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-397176-0.00003-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-397176-0.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-397176-0.00003-0%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bsmall%252Bmolecule%252Bdrug%252Bdiscovery%252Bprocess%252B%2525E2%252580%252593%252Bfrom%252Btarget%252Bselection%252Bto%252Bcandidate%252Bselection%26aulast%3DStocks%26aufirst%3DMichael%26date%3D2013%26spage%3D81%26epage%3D126%26pub%3DElsevier%26atitle%3DIntroduction%252Bto%252BBiological%252Band%252BSmall%252BMolecule%252BDrug%252BResearch%252Band%252BDevelopment%26date%3D2013%26volume%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn P.  Maddaford</span>. </span><span class="cited-content_cbyCitation_article-title">A Medicinal Chemistry Perspective on Structure-Based Drug Design and Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 351-381. <a href="https://doi.org/10.1007/978-1-61779-520-6_15" title="DOI URL">https://doi.org/10.1007/978-1-61779-520-6_15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-61779-520-6_15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-61779-520-6_15%26sid%3Dliteratum%253Aachs%26atitle%3DA%252BMedicinal%252BChemistry%252BPerspective%252Bon%252BStructure-Based%252BDrug%252BDesign%252Band%252BDevelopment%26aulast%3DMaddaford%26aufirst%3DShawn%2BP.%26date%3D2012%26date%3D2011%26spage%3D351%26epage%3D381%26pub%3DHumana%2520Press%26atitle%3DStructure-Based%252BDrug%252BDiscovery%26aulast%3DTari%26aufirst%3DLeslie%2BW.%26date%3D2012%26volume%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xue-lian  Zhu</span>, <span class="hlFld-ContribAuthor ">Hai-yan  Cai</span>, <span class="hlFld-ContribAuthor ">Zhi-jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">He-yao  Wang</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei-liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Classification of 5-HT1A receptor agonists and antagonists using GA-SVM method. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2011,</strong> <em>32 </em>
                                    (11)
                                     , 1424-1430. <a href="https://doi.org/10.1038/aps.2011.112" title="DOI URL">https://doi.org/10.1038/aps.2011.112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/aps.2011.112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Faps.2011.112%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DClassification%252Bof%252B5-HT1A%252Breceptor%252Bagonists%252Band%252Bantagonists%252Busing%252BGA-SVM%252Bmethod%26aulast%3DZhu%26aufirst%3DXue-lian%26date%3D2011%26date%3D2011%26volume%3D32%26issue%3D11%26spage%3D1424%26epage%3D1430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Su</span>, <span class="hlFld-ContribAuthor ">Jian Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Chu Fen  Yang</span>, <span class="hlFld-ContribAuthor ">Ying De  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Facile Synthesis of N-{2-[4-(2-Pyrimidinyl)-1-Piperazinyl]ethyl} Adamantane-1-Carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Applied Mechanics and Materials</span><span> <strong>2011,</strong> <em>117-119 </em>, 1319-1322. <a href="https://doi.org/10.4028/www.scientific.net/AMM.117-119.1319" title="DOI URL">https://doi.org/10.4028/www.scientific.net/AMM.117-119.1319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4028/www.scientific.net/AMM.117-119.1319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4028%2Fwww.scientific.net%2FAMM.117-119.1319%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Mechanics%2520and%2520Materials%26atitle%3DFacile%252BSynthesis%252Bof%252BN-%25257B2-%25255B4-%2525282-Pyrimidinyl%252529-1-Piperazinyl%25255Dethyl%25257D%252BAdamantane-1-Carboxamide%26aulast%3DSu%26aufirst%3DQiang%26date%3D2011%26date%3D2011%26volume%3D117-119%26spage%3D1319%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haitao  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Design: Considerations for Good ADME Properties. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 417-485. <a href="https://doi.org/10.1002/9780470915110.ch11" title="DOI URL">https://doi.org/10.1002/9780470915110.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470915110.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470915110.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BDrug%252BDesign%25253A%252BConsiderations%252Bfor%252BGood%252BADME%252BProperties%26aulast%3DJi%26aufirst%3DHaitao%26date%3D2010%26date%3D2010%26spage%3D417%26epage%3D485%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DADMET%252Bfor%252BMedicinal%252BChemists%26aulast%3DTsaioun%26aufirst%3DKatya%26date%3D2011%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David  Lagorce</span>, <span class="hlFld-ContribAuthor ">Christelle  Reynes</span>, <span class="hlFld-ContribAuthor ">Anne-Claude  Camproux</span>, <span class="hlFld-ContribAuthor ">Maria A.  Miteva</span>, <span class="hlFld-ContribAuthor ">Olivier  Sperandio</span>, <span class="hlFld-ContribAuthor ">Bruno O.  Villoutreix</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico ADME/Tox Predictions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 29-124. <a href="https://doi.org/10.1002/9780470915110.ch2" title="DOI URL">https://doi.org/10.1002/9780470915110.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9780470915110.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9780470915110.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DIn%252BSilico%252BADME%25252FTox%252BPredictions%26aulast%3DLagorce%26aufirst%3DDavid%26date%3D2010%26date%3D2010%26spage%3D29%26epage%3D124%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DADMET%252Bfor%252BMedicinal%252BChemists%26aulast%3DTsaioun%26aufirst%3DKatya%26date%3D2011%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William J.  Pitts</span>. </span><span class="cited-content_cbyCitation_article-title">Immunosuppressive Agents for the Prevention of Transplantation Rejection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 983-1063. <a href="https://doi.org/10.1002/0471266949.bmc206" title="DOI URL">https://doi.org/10.1002/0471266949.bmc206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc206%26sid%3Dliteratum%253Aachs%26atitle%3DImmunosuppressive%252BAgents%252Bfor%252Bthe%252BPrevention%252Bof%252BTransplantation%252BRejection%26aulast%3DPitts%26aufirst%3DWilliam%2BJ.%26date%3D2010%26date%3D2010%26spage%3D983%26epage%3D1063%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emir  Duzic</span>, <span class="hlFld-ContribAuthor ">Michael J.  Marino</span>, <span class="hlFld-ContribAuthor ">Michael  Williams</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor Targets in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,<a href="https://doi.org/10.1002/0471266949.bmc029.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc029.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc029.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc029.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DReceptor%252BTargets%252Bin%252BDrug%252BDiscovery%26aulast%3DDuzic%26aufirst%3DEmir%26date%3D2010%26date%3D2010%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean  Ekins</span>, <span class="hlFld-ContribAuthor ">J. Dana  Honeycutt</span>, <span class="hlFld-ContribAuthor ">James T.  Metz</span>. </span><span class="cited-content_cbyCitation_article-title">Multiobjective Optimization for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 259-278. <a href="https://doi.org/10.1002/0471266949.bmc122" title="DOI URL">https://doi.org/10.1002/0471266949.bmc122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc122%26sid%3Dliteratum%253Aachs%26atitle%3DMultiobjective%252BOptimization%252Bfor%252BDrug%252BDiscovery%26aulast%3DEkins%26aufirst%3DSean%26date%3D2010%26date%3D2010%26spage%3D259%26epage%3D278%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GÃ©raldine  Calvet</span>, <span class="hlFld-ContribAuthor ">Susannah C.  Coote</span>, <span class="hlFld-ContribAuthor ">Nicolas  Blanchard</span>, <span class="hlFld-ContribAuthor ">Cyrille  Kouklovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Î±-Acyloxynitroso dienophiles in [4+2] hetero DielsâAlder cycloadditions: mechanistic insights. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2010,</strong> <em>66 </em>
                                    (16)
                                     , 2969-2980. <a href="https://doi.org/10.1016/j.tet.2010.02.065" title="DOI URL">https://doi.org/10.1016/j.tet.2010.02.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2010.02.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2010.02.065%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3D%2525CE%2525B1-Acyloxynitroso%252Bdienophiles%252Bin%252B%25255B4%25252B2%25255D%252Bhetero%252BDiels%2525E2%252580%252593Alder%252Bcycloadditions%25253A%252Bmechanistic%252Binsights%26aulast%3DCalvet%26aufirst%3DG%25C3%25A9raldine%26date%3D2010%26volume%3D66%26issue%3D16%26spage%3D2969%26epage%3D2980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David J  Newman</span>, <span class="hlFld-ContribAuthor ">Gordon M  Cragg</span>. </span><span class="cited-content_cbyCitation_article-title">Natural product scaffolds as leads to drugs. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2009,</strong> <em>1 </em>
                                    (8)
                                     , 1415-1427. <a href="https://doi.org/10.4155/fmc.09.113" title="DOI URL">https://doi.org/10.4155/fmc.09.113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.09.113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.09.113%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bproduct%252Bscaffolds%252Bas%252Bleads%252Bto%252Bdrugs%26aulast%3DNewman%26aufirst%3DDavid%2BJ%26date%3D2009%26volume%3D1%26issue%3D8%26spage%3D1415%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0005.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Biogenic amines as a starting point for drug design.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of dopaminergic drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structures of serotonergic drug candidates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0001.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Structural Evolution of Effexor</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Major human metabolites of Effexor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High throughput screening of druglike properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Multidimensional lead optimization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0011.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparing the active sites of MMPs and TACE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0002.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Evolution of TMI-005</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0012.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Binding of rapamycin to FKBP and mTOR42.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0003.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Functionalization of C-42 Alcohol Led to the Discovery of Torisel</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0004.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of ILS-920 (<b>13</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Neuroprotective/neuroregenerative activity of compound <b>13</b> on E16 primary rat neurons in culture: (a) effect of <b>13</b> on neuronal survival; (b) compound <b>13</b> promoting neurite outgrowth.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/medium/jm-2008-012823_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Compound <b>13</b> reduces infarct volume in a rat transient mCAO model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-1/jm8012823/production/images/large/jm-2008-012823_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm8012823&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i18">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 51 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Colombo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peretto, I.</span><span> </span><span class="NLM_article-title">Chemical strategies in early drug discovery: an overview of recent trends</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">677</span> <span class="NLM_lpage">684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=677-684&author=M.+Colomboauthor=I.+Peretto&title=Chemical+strategies+in+early+drug+discovery%3A+an+overview+of+recent+trends"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DPeretto%26aufirst%3DI.%26atitle%3DChemical%2520strategies%2520in%2520early%2520drug%2520discovery%253A%2520an%2520overview%2520of%2520recent%2520trends%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D677%26epage%3D684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Fischer, J.</span><span> </span><span class="NLM_article-title">Analog-based drug research: lead and drug optimization</span> <span class="citation_source-journal">Med. Chem. Res.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">12</span> <span class="NLM_fpage">218</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1007%2Fs00044-004-0029-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=218-227&author=J.+Fischer&title=Analog-based+drug+research%3A+lead+and+drug+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs00044-004-0029-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-004-0029-3%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DJ.%26atitle%3DAnalog-based%2520drug%2520research%253A%2520lead%2520and%2520drug%2520optimization%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2004%26volume%3D12%26spage%3D218%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gund, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maliski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, F.</span><span> </span><span class="NLM_article-title">Editorial overview: can drug discovery be industrialized?</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">283</span> <span class="NLM_lpage">284</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVCksrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=283-284&author=P.+Gundauthor=E.+Maliskiauthor=F.+Brown&title=Editorial+overview%3A+can+drug+discovery+be+industrialized%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Editorial overview: Can drug discovery be industrialized?</span></div><div class="casAuthors">Gund, Peter; Maliski, Ed; Brown, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-284</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFDEppr8MtIrVg90H21EOLACvtfcHk0lgy0OyfXzODoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVCksrk%253D&md5=09ac6b5d783104d4c6d0db99a000b169</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGund%26aufirst%3DP.%26aulast%3DMaliski%26aufirst%3DE.%26aulast%3DBrown%26aufirst%3DF.%26atitle%3DEditorial%2520overview%253A%2520can%2520drug%2520discovery%2520be%2520industrialized%253F%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D283%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Stahl, S. M.</span> <span class="citation_source-book">Essential Psychopharmacology: Neuro Scientific Basis and Practical Applications</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2000</span>; Chapter 1, p  <span class="NLM_fpage">52</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&pages=52&author=S.+M.+Stahl&title=Essential+Psychopharmacology%3A+Neuro+Scientific+Basis+and+Practical+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%2BM.%26btitle%3DEssential%2520Psychopharmacology%253A%2520Neuro%2520Scientific%2520Basis%2520and%2520Practical%2520Applications%26pub%3DCambridge%2520University%2520Press%26date%3D2000%26spage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Dean, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarr, E.</span><span> </span><span class="NLM_article-title">Antipsychotic drugs: evolving mechanisms of action with improved therapeutic benefits</span> <span class="citation_source-journal">Curr. Drug Targets: CNS Neurol. Disord.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">217</span> <span class="NLM_lpage">225</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F1568007043337373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15180482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=217-225&author=B.+Deanauthor=E.+Scarr&title=Antipsychotic+drugs%3A+evolving+mechanisms+of+action+with+improved+therapeutic+benefits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antipsychotic drugs: Evolving mechanisms of action with improved therapeutic benefits</span></div><div class="casAuthors">Dean, B.; Scarr, E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">217-225</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  One of the conundrums of neuropharmacol. is to understand the therapeutic mechanisms of action of antipsychotic drugs.  Every drug with antipsychotic activity is a dopamine (DA) D2-like receptor antagonist and therefore this function is crit. to reducing psychotic symptoms.  However, the actions of the archetypal atypical antipsychotic drug clozapine go beyond antipsychotic effects because the drug is efficacious in treating psychotic symptoms that do not respond to drugs mainly directed at antagonizing the DA D2 receptor, has benefits in cognition, and has recently been shown to reduce levels of suicide.  A growing understanding of the mechanisms of clozapine and other atypical antipsychotic drugs suggests that both partial and inverse agonism, as well as receptor antagonism, at specific neurotransmitter receptors is required to give full therapeutic benefits.  It is, therefore, timely to review the evolving nature of the mechanisms of action of different antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8KWcEfmek8bVg90H21EOLACvtfcHk0lgy0OyfXzODoQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7c%253D&md5=62dfdc336bd5ed2e0c412edfe4da90b5</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F1568007043337373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337373%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DB.%26aulast%3DScarr%26aufirst%3DE.%26atitle%3DAntipsychotic%2520drugs%253A%2520evolving%2520mechanisms%2520of%2520action%2520with%2520improved%2520therapeutic%2520benefits%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D217%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Reynolds, G. P.</span><span> </span><span class="NLM_article-title">Receptor mechanisms in the treatment of schizophrenia</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">340</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1177%2F026988110401800303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15358977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsl2nu7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=340-345&author=G.+P.+Reynolds&title=Receptor+mechanisms+in+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor mechanisms in the treatment of schizophrenia</span></div><div class="casAuthors">Reynolds, Gavin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">340-345</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  There remain many limitations to the treatment of schizophrenia.  In addn. to the poor response of neg. and cognitive symptoms to antipsychotics, and the substantial proportion of poor- or non-responders, there are a variety of unpleasant and restricting side-effects of these drugs.  The introduction of several 'atypical' drugs, with diminished propensity to cause extrapyramidal motor effects (EPS), has greatly improved the tolerability of antipsychotic treatments.  The pharmacol. of atypical antipsychotics is varied and, although dopamine D2 receptor antagonism is common to all antipsychotics, the mechanisms of atypicality are complex and not fully understood.  Thus, antagonism at 5-HT2 and/or other receptors, weak dopamine receptor affinity and, most recently, partial agonism at dopamine D2 receptors, have been variously implicated.  However, because EPS have diminished with improvements in drug treatment, drug-induced wt. gain has emerged as a major concern, and the pharmacol. basis of this problem, involving effects at 5-HT2c and perhaps other receptors, is yielding to investigation.  Some drugs, notably the D2 partial agonists, can provide antipsychotic effects without the emergence of several of these problematic side-effects, which bodes well for future treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiggMHmrWKx7Vg90H21EOLACvtfcHk0ljvi0Xt957USQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsl2nu7o%253D&md5=6a83d8c0c99562441e27ba78b15dcb1b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1177%2F026988110401800303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110401800303%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DG.%2BP.%26atitle%3DReceptor%2520mechanisms%2520in%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2004%26volume%3D18%26spage%3D340%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Antipsychotic activity of substituted Î³-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1987</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">1818</span> <span class="NLM_lpage">1823</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1818-1823&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=M.+Webbauthor=J.+Moyerauthor=T.+Andreeauthor=E.+Muth&title=Antipsychotic+activity+of+substituted+%CE%B3-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a023%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DAntipsychotic%2520activity%2520of%2520substituted%2520%25CE%25B3-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1818%26epage%3D1823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">WY-47,384</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">541</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1988&pages=541-549&author=M.+Abou-Gharbiaauthor=T.+Andree&title=WY-47%2C384"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DWY-47%252C384%26jtitle%3DDrugs%2520Future%26date%3D1988%26volume%3D13%26spage%3D541%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Behavioral pharmacology of the gamma carboline WY-47,384: a potential antipsychotic agent</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">11</span> <span class="NLM_lpage">28</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1988&pages=11-28&author=J.+Moyerauthor=M.+Abou-Gharbiaauthor=E.+Muth&title=Behavioral+pharmacology+of+the+gamma+carboline+WY-47%2C384%3A+a+potential+antipsychotic+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DBehavioral%2520pharmacology%2520of%2520the%2520gamma%2520carboline%2520WY-47%252C384%253A%2520a%2520potential%2520antipsychotic%2520agent%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1988%26volume%3D13%26spage%3D11%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Psychotropic agents: synthesis and antipsychotic activity of substituted Î²-carbolines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1987</span> <span class="NLM_volume">30</span> <span class="NLM_fpage">1100</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00389a022" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1100-1105&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=J.+Moyerauthor=E.+Muth&title=Psychotropic+agents%3A+synthesis+and+antipsychotic+activity+of+substituted+%CE%B2-carbolines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm00389a022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00389a022%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DPsychotropic%2520agents%253A%2520synthesis%2520and%2520antipsychotic%2520activity%2520of%2520substituted%2520%25CE%25B2-carbolines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1100%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">WY-47,791. Antipsychotic</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1991</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1008</span> <span class="NLM_lpage">1013</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1991&pages=1008-1013&author=M.+Abou-Gharbiaauthor=K.+Marquisauthor=T.+Andree&title=WY-47%2C791.+Antipsychotic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DWY-47%252C791.%2520Antipsychotic%26jtitle%3DDrugs%2520Future%26date%3D1991%26volume%3D16%26spage%3D1008%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildersleeve, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochalski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span> </span><span class="NLM_article-title">New generation dopaminergic agents. 2. Discovery of 3-OH-phenoxyethylamine and 3-OH-N1-phenylpiperazine dopaminergic templates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">295</span> <span class="NLM_lpage">300</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=295-300&author=R.+E.+Mewshawauthor=M.+Husbandsauthor=E.+S.+Gildersleeveauthor=M.+B.+Webbauthor=X.+Shiauthor=H.+Mazandaraniauthor=M.+I.+Cockettauthor=R.+Ochalskiauthor=J.+A.+Brennanauthor=M.+Abou-Gharbiaauthor=K.+Marquisauthor=J.+Coupetauthor=T.+Andree&title=New+generation+dopaminergic+agents.+2.+Discovery+of+3-OH-phenoxyethylamine+and+3-OH-N1-phenylpiperazine+dopaminergic+templates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DHusbands%26aufirst%3DM.%26aulast%3DGildersleeve%26aufirst%3DE.%2BS.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DOchalski%26aufirst%3DR.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26atitle%3DNew%2520generation%2520dopaminergic%2520agents.%25202.%2520Discovery%2520of%25203-OH-phenoxyethylamine%2520and%25203-OH-N1-phenylpiperazine%2520dopaminergic%2520templates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D295%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Mewshaw, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanagh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kagan, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes-Burgos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazandarani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockett, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochalski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coupet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structureâactivity relationships of a series of 2-aminomethyl chromans</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">40</span> <span class="NLM_fpage">4235</span> <span class="NLM_lpage">4256</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9703653" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4235-4256&author=R.+E.+Mewshawauthor=J.+Kavanaghauthor=G.+Stackauthor=K.+L.+Marquisauthor=X.+Shiauthor=M.+Z.+Kaganauthor=M.+B.+Webbauthor=A.+H.+Katzauthor=A.+Parkauthor=Y.+H.+Kangauthor=M.+Abou-Gharbiaauthor=R.+Scerniauthor=T.+Wasikauthor=L.+Cortes-Burgosauthor=T.+Spanglerauthor=J.+A.+Brennanauthor=M.+Pieslaauthor=H.+Mazandaraniauthor=M.+I.+Cockettauthor=R.+Ochalskiauthor=J.+Coupetauthor=T.+H.+Andree&title=New+generation+dopaminergic+agents.+1.+Discovery+of+a+novel+scaffold+which+embraces+the+D2+agonist+pharmacophore.+Structure%E2%88%92activity+relationships+of+a+series+of+2-aminomethyl+chromans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm9703653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9703653%26sid%3Dliteratum%253Aachs%26aulast%3DMewshaw%26aufirst%3DR.%2BE.%26aulast%3DKavanagh%26aufirst%3DJ.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DK.%2BL.%26aulast%3DShi%26aufirst%3DX.%26aulast%3DKagan%26aufirst%3DM.%2BZ.%26aulast%3DWebb%26aufirst%3DM.%2BB.%26aulast%3DKatz%26aufirst%3DA.%2BH.%26aulast%3DPark%26aufirst%3DA.%26aulast%3DKang%26aufirst%3DY.%2BH.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DWasik%26aufirst%3DT.%26aulast%3DCortes-Burgos%26aufirst%3DL.%26aulast%3DSpangler%26aufirst%3DT.%26aulast%3DBrennan%26aufirst%3DJ.%2BA.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DMazandarani%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DOchalski%26aufirst%3DR.%26aulast%3DCoupet%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DNew%2520generation%2520dopaminergic%2520agents.%25201.%2520Discovery%2520of%2520a%2520novel%2520scaffold%2520which%2520embraces%2520the%2520D2%2520agonist%2520pharmacophore.%2520Structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520series%2520of%25202-aminomethyl%2520chromans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4235%26epage%3D4256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Heinrich, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hormby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popiolek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pausch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span> </span><span class="NLM_article-title">Aplindore (DAB-452): a high affinity selective dopamine D2 partial agonist</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">552</span> <span class="NLM_fpage">36</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1016%2Fj.ejphar.2006.08.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17056032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKmurvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2006&pages=36-45&author=J.+N.+Heinrichauthor=J.+Brennanauthor=M.+H.+Laiauthor=K.+Sullivanauthor=G.+Hormbyauthor=M.+Popiolekauthor=L.-X.+Jiangauthor=M.+H.+Pauschauthor=G.+Stackauthor=K.+Marquisauthor=T.+H.+Andree&title=Aplindore+%28DAB-452%29%3A+a+high+affinity+selective+dopamine+D2+partial+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist</span></div><div class="casAuthors">Heinrich, Julia N.; Brennan, Julie; Lai, Margaret H.; Sullivan, Kelly; Hornby, Geoff; Popiolek, Mike; Jiang, Li-Xin; Pausch, Mark H.; Stack, Gary; Marquis, Karen L.; Andree, Terrance H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">36-45</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The pharmacol. of aplindore (DAB-452) was characterized in CHO-K1 cells stably transfected with the human dopamine D2 receptor short isoform (CHO-D2s) and in a behavioral model for postsynaptic agonism in rats.  In [3H]-spiperone competition binding studies, aplindore showed high affinity for dopamine D2 and D3 receptors and low affinity for the dopamine D4, serotonin (5-HT)1A, 5-HT2 receptors and the Î±1-adrenoceptor.  The high potency partial agonist activity of aplindore was demonstrated in [35S]guanosine 5'-O-(3-thiotriphosphate) ([35S]GTPÎ³S) binding, extracellular signal-regulated kinase (ERK)-phosphorylation and intracellular calcium flux assay using fluorometric plate reader ([Ca2+]i-FLIPR) format.  The [Ca2+]i-FLIPR assay was conducted with CHO-D2S receptor cells also stably expressing chimeric GÎ±q/o-proteins.  In all assay modalities, the potencies and intrinsic activities of aplindore were lower than dopamine and higher than aripiprazole.  In contrast to the [35S]GTPÎ³S binding and ERK-phosphorylation assays, the [Ca2+]i-FLIPR assay was able to detect the low partial agonist activity of SDZ 208-912.  In unilaterally 6-hydroxydopamine (6-OHDA) lesioned rats, aplindore induced contralateral turning, which was blocked by the dopamine D2 receptor antagonist raclopride.  The dopamine D2 receptor selective partial agonist profile of aplindore suggests that it should be effective for the treatment of dopaminergic-based disorders, such as schizophrenia and Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLHRpcmHQzCbVg90H21EOLACvtfcHk0lifCJyU-es7iw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKmurvK&md5=b40dfb12115516073cb16c548432461b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.063%26sid%3Dliteratum%253Aachs%26aulast%3DHeinrich%26aufirst%3DJ.%2BN.%26aulast%3DBrennan%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DM.%2BH.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DHormby%26aufirst%3DG.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DL.-X.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26atitle%3DAplindore%2520%2528DAB-452%2529%253A%2520a%2520high%2520affinity%2520selective%2520dopamine%2520D2%2520partial%2520agonist%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D552%26spage%3D36%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Arvidsson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hacksell, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjorth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikstrom, H.</span><span> </span><span class="NLM_article-title">8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1981</span> <span class="NLM_volume">24</span> <span class="NLM_fpage">921</span> <span class="NLM_lpage">923</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00140a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=921-923&author=L.+E.+Arvidssonauthor=U.+Hacksellauthor=J.+L.+Nilssonauthor=S.+Hjorthauthor=A.+Carlssonauthor=P.+Lindbergauthor=D.+Sanchezauthor=H.+Wikstrom&title=8-Hydroxy-2-%28dipropylamino%29tetralin%2C+a+new+centrally+acting+5-hydroxytryptamine+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm00140a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00140a002%26sid%3Dliteratum%253Aachs%26aulast%3DArvidsson%26aufirst%3DL.%2BE.%26aulast%3DHacksell%26aufirst%3DU.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DHjorth%26aufirst%3DS.%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindberg%26aufirst%3DP.%26aulast%3DSanchez%26aufirst%3DD.%26aulast%3DWikstrom%26aufirst%3DH.%26atitle%3D8-Hydroxy-2-%2528dipropylamino%2529tetralin%252C%2520a%2520new%2520centrally%2520acting%25205-hydroxytryptamine%2520receptor%2520agonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D921%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E.</span><span> </span><span class="NLM_article-title">Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structureâactivity relationship studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1988</span> <span class="NLM_volume">31</span> <span class="NLM_fpage">1382</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00402a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1382-1392&author=M.+Abou-Gharbiaauthor=U.+Patelauthor=M.+Webbauthor=J.+Moyerauthor=T.+Andreeauthor=E.+Muth&title=Polycyclic+aryl-+and+heteroarylpiperazinyl+imides+as+5-HT1A+receptor+ligands+and+potential+anxiolytic+agents%3A+synthesis+and+structure%E2%88%92activity+relationship+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm00402a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00402a023%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DMuth%26aufirst%3DE.%26atitle%3DPolycyclic%2520aryl-%2520and%2520heteroarylpiperazinyl%2520imides%2520as%25205-HT1A%2520receptor%2520ligands%2520and%2520potential%2520anxiolytic%2520agents%253A%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1382%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Haskins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span> </span><span class="NLM_article-title">Preclinical anxiolytic profile of the pyrimidinylpiperazinyl imide compound WY-47,846</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">18</span> <span class="NLM_fpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1989&pages=29&author=J.+T.+Haskinsauthor=J.+A.+Moyerauthor=T.+H.+Andreeauthor=E.+A.+Muthauthor=M.+Abou-Gharbia&title=Preclinical+anxiolytic+profile+of+the+pyrimidinylpiperazinyl+imide+compound+WY-47%2C846"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaskins%26aufirst%3DJ.%2BT.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26atitle%3DPreclinical%2520anxiolytic%2520profile%2520of%2520the%2520pyrimidinylpiperazinyl%2520imide%2520compound%2520WY-47%252C846%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1989%26volume%3D18%26spage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haskins, J. T.</span><span> </span><span class="NLM_article-title">WY-47,846</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1989</span> <span class="NLM_volume">14</span><span class="NLM_issue">5</span> <span class="NLM_fpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=442&issue=5&author=M.+Abou-Gharbiaauthor=J.+Moyerauthor=J.+T.+Haskins&title=WY-47%2C846"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26aulast%3DHaskins%26aufirst%3DJ.%2BT.%26atitle%3DWY-47%252C846%26jtitle%3DDrugs%2520Future%26date%3D1989%26volume%3D14%26issue%3D5%26spage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span> </span><span class="NLM_article-title">WY-50,324, anxiolytic/antidepressant</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">15</span><span class="NLM_issue">11</span> <span class="NLM_fpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1990&pages=1093&issue=11&author=M.+Abou-Gharbiaauthor=J.+Moyer&title=WY-50%2C324%2C+anxiolytic%2Fantidepressant"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DMoyer%26aufirst%3DJ.%26atitle%3DWY-50%252C324%252C%2520anxiolytic%252Fantidepressant%26jtitle%3DDrugs%2520Future%26date%3D1990%26volume%3D15%26issue%3D11%26spage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yardley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boast, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucharik, R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scerni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J.</span><span> </span><span class="NLM_article-title">Sythesis and SAR of adatanserin: novel adamantly aryl- and heteroarylpiperazines with dual 5-HT1A and 5-HT2 activity as potential anxiolytic and antidepressant agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">42</span> <span class="NLM_fpage">5077</span> <span class="NLM_lpage">5094</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9806704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=5077-5094&author=M.+Abou-Gharbiaauthor=W.+Childersauthor=H.+Fletcherauthor=G.+McGaugheyauthor=U.+Patelauthor=M.+Webbauthor=J.+Yardleyauthor=T.+Andreeauthor=C.+Boastauthor=R.+Kucharikauthor=K.+Marquisauthor=M.+H.+Husbandsauthor=R.+Scerniauthor=J.+Moyer&title=Sythesis+and+SAR+of+adatanserin%3A+novel+adamantly+aryl-+and+heteroarylpiperazines+with+dual+5-HT1A+and+5-HT2+activity+as+potential+anxiolytic+and+antidepressant+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm9806704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9806704%26sid%3Dliteratum%253Aachs%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DChilders%26aufirst%3DW.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DWebb%26aufirst%3DM.%26aulast%3DYardley%26aufirst%3DJ.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DBoast%26aufirst%3DC.%26aulast%3DKucharik%26aufirst%3DR.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DHusbands%26aufirst%3DM.%2BH.%26aulast%3DScerni%26aufirst%3DR.%26aulast%3DMoyer%26aufirst%3DJ.%26atitle%3DSythesis%2520and%2520SAR%2520of%2520adatanserin%253A%2520novel%2520adamantly%2520aryl-%2520and%2520heteroarylpiperazines%2520with%2520dual%25205-HT1A%2520and%25205-HT2%2520activity%2520as%2520potential%2520anxiolytic%2520and%2520antidepressant%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D5077%26epage%3D5094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hornby, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potestio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schecter, L. E.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of benzodioxanylpiperazines as potent serotonin 5-HT1A antagonists: the discovery of lecozotan</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">48</span><span class="NLM_issue">10</span> <span class="NLM_fpage">3467</span> <span class="NLM_lpage">3470</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049493z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3467-3470&issue=10&author=W.+E.+Childersauthor=M.+G.+Kellyauthor=M.+A.+Abou-Gharbiaauthor=T.+H.+Andreeauthor=B.+L.+Harrisonauthor=G.+Hornbyauthor=L.+Potestioauthor=S.+J.+Rosenzweig-Lipsonauthor=J.+Schmidauthor=D.+L.+Smithauthor=S.+J.+Sukoffauthor=G.+Zhangauthor=L.+E.+Schecter&title=Synthesis+and+biological+evaluation+of+benzodioxanylpiperazines+as+potent+serotonin+5-HT1A+antagonists%3A+the+discovery+of+lecozotan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm049493z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049493z%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DKelly%26aufirst%3DM.%2BG.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHornby%26aufirst%3DG.%26aulast%3DPotestio%26aufirst%3DL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%2BJ.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DSchecter%26aufirst%3DL.%2BE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520benzodioxanylpiperazines%2520as%2520potent%2520serotonin%25205-HT1A%2520antagonists%253A%2520the%2520discovery%2520of%2520lecozotan%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D10%26spage%3D3467%26epage%3D3470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Childers, W. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parks, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schechter, L. E.</span><span> </span><span class="NLM_article-title">Lecozotan</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">32</span> <span class="NLM_fpage">399</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1358%2Fdof.2007.032.05.1092901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=399-407&author=W.+E.+Childersauthor=B.+L.+Harrisonauthor=M.+A.+Abou-Gharbiaauthor=S.+Rajeauthor=V.+Parksauthor=M.+N.+Pangalosauthor=L.+E.+Schechter&title=Lecozotan"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Cognition enhancer treatment of Alzheimer's disease competitive 5-HT1A receptor antagonist</span></div><div class="casAuthors">Childers, Wayne E., Jr.; Harrison, Boyd L.; Abou-Gharbia, Magid A.; Raje, Sangeeta; Parks, Virginia; Pangalos, Menelas N.; Schechter, Lee E.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Lecozotan is a potent, selective, competitive, orally active antagonist of the serotonin 5-HT1A receptor in development for the symptomatic treatment of cognitive deficits such as those seen in Alzheimer's disease.  The agent shows no intrinsic activity in a no. of in vitro and in vivo assays, supporting the conclusion that it is a full antagonist under several conditions.  In vivo, lecozotan enhances the potassium-stimulated release of both acetylcholine and glutamate, and it improves cognitive performance in multiple animal models of learning and memory.  The compd. was well tolerated in single- and multiple-ascending-dose (SAD and MAD) safety trials in both young and elderly subjects at total daily doses up to and including 10 mg (5 mg every 12 h) for the immediate-release formulation.  Sustained-release formulations have been developed which provide favorable pharmacokinetics for once-daily dosing.  Lecozotan is currently under investigation in advanced phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRzPkCOymtxrVg90H21EOLACvtfcHk0lhmMEfHCjbw8A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFWqsbg%253D&md5=5149bb9b594cbc636ef22b9e7f57f10c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1358%2Fdof.2007.032.05.1092901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2007.032.05.1092901%26sid%3Dliteratum%253Aachs%26aulast%3DChilders%26aufirst%3DW.%2BE.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26aulast%3DRaje%26aufirst%3DS.%26aulast%3DParks%26aufirst%3DV.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26atitle%3DLecozotan%26jtitle%3DDrugs%2520Future%26date%3D2007%26volume%3D32%26spage%3D399%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schechter, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenzweig-Lipson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukoff, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piesla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nawoschik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harder, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccafusco, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terry, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoebel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rada, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childers, W.</span><span> </span><span class="NLM_article-title">Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">314</span> <span class="NLM_fpage">1274</span> <span class="NLM_lpage">1289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1124%2Fjpet.105.086363" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15951399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1274-1289&author=L.+E.+Schechterauthor=D.+L.+Smithauthor=S.+Rosenzweig-Lipsonauthor=S.+J.+Sukoffauthor=L.+A.+Dawsonauthor=K.+Marquisauthor=D.+Jonesauthor=M.+Pieslaauthor=T.+Andreeauthor=S.+Nawoschikauthor=J.+A.+Harderauthor=M.+D.+Womackauthor=J.+Buccafuscoauthor=A.+V.+Terryauthor=B.+Hoebelauthor=P.+Radaauthor=M.+Kellyauthor=M.+Abou-Gharbiaauthor=J.+E.+Barrettauthor=W.+Childers&title=Lecozotan+%28SRA-333%29%3A+a+selective+serotonin+1A+receptor+antagonist+that+enhances+the+stimulated+release+of+glutamate+and+acetylcholine+in+the+hippocampus+and+possesses+cognitive-enhancing+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Lecozotan (SRA-333): A selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties</span></div><div class="casAuthors">Schechter, L. E.; Smith, D. L.; Rosenzweig-Lipson, S.; Sukoff, S. J.; Dawson, L. A.; Marquis, K.; Jones, D.; Piesla, M.; Andree, T.; Nawoschik, S.; Harder, J. A.; Womack, M. D.; Buccafusco, J.; Terry, A. V.; Hoebel, B.; Rada, P.; Kelly, M.; Abou-Gharbia, M.; Barrett, J. E.; Childers, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1289</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent data has suggested that the 5-hydroxytryptamine (5-HT)1A receptor is involved in cognitive processing.  A novel 5-HT1A receptor antagonist, 4-cyano-N-{2R-[4-(2,3-dihydrobenzo[1,4]-dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide HCl (lecozotan), which has been characterized in multiple in vitro and in vivo pharmacol. assays as a drug to treat cognitive dysfunction, is reported.  In vitro binding and intrinsic activity detns. demonstrated that lecozotan is a potent and selective 5-HT1A receptor antagonist.  Using in vivo microdialysis, lecozotan (0.3 mg/kg s.c.) antagonized the decrease in hippocampal extracellular 5-HT induced by a challenge dose (0.3 mg/kg s.c.) of 8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT) and had no effects alone at doses 10-fold higher.  Lecozotan significantly potentiated the potassium chloride-stimulated release of glutamate and acetylcholine in the dentate gyrus of the hippocampus.  Chronic administration of lecozotan did not induce 5-HT1A receptor tolerance or desensitization in a behavioral model indicative of 5-HT1A receptor function.  In drug discrimination studies, lecozotan (0.01-1 mg/kg i.m.) did not substitute for 8-OH-DPAT and produced a dose-related blockade of the 5-HT1A agonist discriminative stimulus cue.  In aged rhesus monkeys, lecozotan produced a significant improvement in task performance efficiency at an optimal dose (1 mg/kg p.o.).  Learning deficits induced by the glutamatergic antagonist MK-801 [(-)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate] (assessed by perceptually complex and visual spatial discrimination) and by specific cholinergic lesions of the hippocampus (assessed by visual spatial discrimination) were reversed by lecozotan (2 mg/kg i.m.) in marmosets.  The heterosynaptic nature of the effects of lecozotan imbues this compd. with a novel mechanism of action directed at the biochem. pathologies underlying cognitive loss in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDog5bWsysrLVg90H21EOLACvtfcHk0lgwwczZ7qvM0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsbw%253D&md5=4d07a0db6675ddc2238dcca19a4c68b7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.086363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.086363%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DL.%2BE.%26aulast%3DSmith%26aufirst%3DD.%2BL.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DSukoff%26aufirst%3DS.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DMarquis%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DPiesla%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DNawoschik%26aufirst%3DS.%26aulast%3DHarder%26aufirst%3DJ.%2BA.%26aulast%3DWomack%26aufirst%3DM.%2BD.%26aulast%3DBuccafusco%26aufirst%3DJ.%26aulast%3DTerry%26aufirst%3DA.%2BV.%26aulast%3DHoebel%26aufirst%3DB.%26aulast%3DRada%26aufirst%3DP.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DJ.%2BE.%26aulast%3DChilders%26aufirst%3DW.%26atitle%3DLecozotan%2520%2528SRA-333%2529%253A%2520a%2520selective%2520serotonin%25201A%2520receptor%2520antagonist%2520that%2520enhances%2520the%2520stimulated%2520release%2520of%2520glutamate%2520and%2520acetylcholine%2520in%2520the%2520hippocampus%2520and%2520possesses%2520cognitive-enhancing%2520properties%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1274%26epage%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Yardley, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Husbands, G. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stack, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bicksler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moyer, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muth, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andree, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sielecki, A.</span><span> </span><span class="NLM_article-title">2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_year" style="font-weight: bold;">1990</span> <span class="NLM_volume">33</span> <span class="NLM_fpage">2899</span> <span class="NLM_lpage">2905</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00172a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2899-2905&author=J.+P.+Yardleyauthor=G.+E.+M.+Husbandsauthor=G.+Stackauthor=J.+Butchauthor=J.+Bickslerauthor=J.+A.+Moyerauthor=E.+A.+Muthauthor=T.+Andreeauthor=H.+Fletcherauthor=M.+N.+G.+Jamesauthor=A.+Sielecki&title=2-Phenyl-2-%281-hydroxycycloalkyl%29ethylamine+derivatives%3A+synthesis+and+antidepressant+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm00172a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00172a035%26sid%3Dliteratum%253Aachs%26aulast%3DYardley%26aufirst%3DJ.%2BP.%26aulast%3DHusbands%26aufirst%3DG.%2BE.%2BM.%26aulast%3DStack%26aufirst%3DG.%26aulast%3DButch%26aufirst%3DJ.%26aulast%3DBicksler%26aufirst%3DJ.%26aulast%3DMoyer%26aufirst%3DJ.%2BA.%26aulast%3DMuth%26aufirst%3DE.%2BA.%26aulast%3DAndree%26aufirst%3DT.%26aulast%3DFletcher%26aufirst%3DH.%26aulast%3DJames%26aufirst%3DM.%2BN.%2BG.%26aulast%3DSielecki%26aufirst%3DA.%26atitle%3D2-Phenyl-2-%25281-hydroxycycloalkyl%2529ethylamine%2520derivatives%253A%2520synthesis%2520and%2520antidepressant%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2899%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Thase, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Entsuah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, R.</span><span> </span><span class="NLM_article-title">Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">178</span> <span class="NLM_fpage">234</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1192%2Fbjp.178.3.234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=11230034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A280%3ADC%252BD3M3jsF2nsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2001&pages=234-241&author=M.+E.+Thaseauthor=R.+Entsuahauthor=R.+Rudolph&title=Remission+rates+during+treatment+with+venlafaxine+or+selective+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors</span></div><div class="casAuthors">Thase M E; Entsuah A R; Rudolph R L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-41</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">BACKGROUND:  It had been suggested that the antidepressant venlafaxine, which inhibits reuptake of both serotonin and (at higher doses) noradrenaline, may result in better outcomes than treatment with selective serotonin reuptake inhibitors (SSRIs).  AIMS:  To compare remission rates during treatment with SSRIs or venlafaxine.  METHOD:  Data from eight comparable randomised, double-blind studies of major depressive disorder were pooled to compare remission rates (Hamilton Rating Scale for Depression score < or = 7) during treatment with venlafaxine (n = 851), SSRIs (fluoxetine, paroxetine, fluvoxamine; n = 748) or placebo (four studies; n = 446).  RESULTS:  Remission rates were: venlafaxine, 45% (382/851); SSRIs, 35% (260/748); placebo, 25% (110/446) (P: < 0.001; odds ratio for remission is 1.50 (1.3-1.9), favouring venlafaxine v.  SSRIs).  The difference between venlafaxine and the SSRIs was significant at week 2, whereas the difference between SSRIs and placebo reached significance at week 4.  Results were not dependent on any one study or the definition of remission.  CONCLUSIONS:  Remission rates were significantly higher with venlafaxine than with an SSRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSs9tUzV0t0zlMGsG_HTXYFfW6udTcc2eYqBy0OXUceE7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3jsF2nsA%253D%253D&md5=b3d4837133664af7621f670ed2743eed</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1192%2Fbjp.178.3.234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.178.3.234%26sid%3Dliteratum%253Aachs%26aulast%3DThase%26aufirst%3DM.%2BE.%26aulast%3DEntsuah%26aufirst%3DR.%26aulast%3DRudolph%26aufirst%3DR.%26atitle%3DRemission%2520rates%2520during%2520treatment%2520with%2520venlafaxine%2520or%2520selective%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D178%26spage%3D234%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Septien-Velez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitrosky, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padmanabhan, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germain, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tourian, K.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder</span> <span class="citation_source-journal">Int. Clin. Psychopharmacol.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">22</span><span class="NLM_issue">6</span> <span class="NLM_fpage">338</span> <span class="NLM_lpage">353</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1097%2FYIC.0b013e3281e2c84b" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17917552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A280%3ADC%252BD2srpsFKrsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=338-353&issue=6&author=L.+Septien-Velezauthor=B.+Pitroskyauthor=S.+K.+Padmanabhanauthor=J.-M.+Germainauthor=K.+Tourian&title=A+randomized%2C+double-blind%2C+placebo-controlled+trial+of+desvenlafaxine+succinate+in+the+treatment+of+major+depressive+disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder</span></div><div class="casAuthors">Septien-Velez Lucia; Pitrosky Bruno; Padmanabhan Sudharshan Krishna; Germain Jean-Michel; Tourian Karen A</div><div class="citationInfo"><span class="NLM_cas:title">International clinical psychopharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">338-47</span>
        ISSN:<span class="NLM_cas:issn">0268-1315</span>.
    </div><div class="casAbstract">The antidepressant efficacy and safety of desvenlafaxine succinate (desvenlafaxine) were evaluated in a phase III, double-blind, placebo-controlled study.  Outpatients with a primary diagnosis of major depressive disorder were treated with fixed once-daily doses of desvenlafaxine 200 or 400 mg for 8 weeks.  The primary efficacy measure was change from baseline on the 17-item Hamilton Rating Scale for Depression.  At the final on-therapy evaluation, adjusted mean change from baseline in 17-item Hamilton Rating Scale for Depression total score was greater for desvenlafaxine 200 and 400 mg/day vs. placebo.  Both desvenlafaxine doses showed greater efficacy than placebo on the secondary efficacy measures, including the Clinical Global Impressions-Improvement scale scores, Montgomery-Asberg Depression Rating Scale scores, CGI-Severity, and 17-item Hamilton Rating Scale for Depression response rate.  Desvenlafaxine 200 mg/day was also significantly better than placebo on remission, Visual Analog Scale-Pain Intensity overall scores, and some Visual Analog Scale-Pain Intensity subscale scores.  Desvenlafaxine 400 mg/day was significantly better than placebo on selected Visual Analog Scale-Pain Intensity subscale scores.  Most adverse events were mild or moderate in severity, and safety assessments revealed few clinically significant changes in vital signs, laboratory tests, and electrocardiogram results.  These data provide support for the efficacy and safety of desvenlafaxine in the treatment of major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-3qwLgEqxGYNpW7w2tapOfW6udTcc2eYQGPayH7RMmrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srpsFKrsg%253D%253D&md5=d69928308b3c7a4fb5b0b6721d2737a1</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1097%2FYIC.0b013e3281e2c84b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FYIC.0b013e3281e2c84b%26sid%3Dliteratum%253Aachs%26aulast%3DSeptien-Velez%26aufirst%3DL.%26aulast%3DPitrosky%26aufirst%3DB.%26aulast%3DPadmanabhan%26aufirst%3DS.%2BK.%26aulast%3DGermain%26aufirst%3DJ.-M.%26aulast%3DTourian%26aufirst%3DK.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520trial%2520of%2520desvenlafaxine%2520succinate%2520in%2520the%2520treatment%2520of%2520major%2520depressive%2520disorder%26jtitle%3DInt.%2520Clin.%2520Psychopharmacol.%26date%3D2007%26volume%3D22%26issue%3D6%26spage%3D338%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span> </span><span class="NLM_article-title">Integrity profiling of high throughput screening hits using LCâMS and related techniques</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">8</span> <span class="NLM_fpage">459</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F1386207054867283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=16178805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslOnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=459-466&author=E.+H.+Kernsauthor=L.+Di&title=Integrity+profiling+of+high+throughput+screening+hits+using+LC%E2%88%92MS+and+related+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Integrity profiling of high throughput screening hits using LC-MS and related techniques</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Bourassa, Jim; Gross, Jonathan; Huang, Nelson; Liu, Hanlan; Kleintop, Teresa; Nogle, Lisa; Mallis, Larry; Petucci, Chris; Petusky, Susan; Tischler, Mark; Sabus, Chantel; Sarkahian, Ani; Young, Mairead; Zhang, Mei-yi; Huryn, Donna; McConnell, Oliver; Carter, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry and High Throughput Screening</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">459-466</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrity profiling of HTS hits is valuable for verification of the hit identity and purity.  This provides early discovery researchers with more confident SAR theories.  Methodol. for integrity profiling of HTS hits must be high throughput, consume little material, and selectively provide structure-based data.  Anal. techniques that can be utilized for integrity profiling methods are reviewed for their appropriateness in sample prepn., component sepn., detection, purity quantitation, identity confirmation, and follow-up.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-CVqhdtheP7Vg90H21EOLACvtfcHk0lhFpJvHNx8Pug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslOnurs%253D&md5=bc75cbcb60b00fd34e14ea3663969826</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.2174%2F1386207054867283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1386207054867283%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DIntegrity%2520profiling%2520of%2520high%2520throughput%2520screening%2520hits%2520using%2520LC%25E2%2588%2592MS%2520and%2520related%2520techniques%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2005%26volume%3D8%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kerns, E. H.; Di, L.</span> In  <span class="citation_source-book">Integrated Strategies for Drug Discovery Using Mass Spectrometry</span>; <span class="NLM_contrib-group">Lee, M. S.</span>, Ed.; <span class="NLM_publisher-name">Wiley Interscience</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">1988</span>; pp  <span class="NLM_fpage">433</span>â <span class="NLM_lpage">458</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1988&pages=433-458&author=E.+H.+Kerns&author=L.+Diauthor=M.+S.+Lee&title=Integrated+Strategies+for+Drug+Discovery+Using+Mass+Spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26btitle%3DIntegrated%2520Strategies%2520for%2520Drug%2520Discovery%2520Using%2520Mass%2520Spectrometry%26aulast%3DLee%26aufirst%3DM.%2BS.%26pub%3DWiley%2520Interscience%26date%3D1988%26spage%3D433%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span> </span><span class="NLM_article-title">Utility of mass spectrometry for pharmaceutical profiling applications</span> <span class="citation_source-journal">Curr. Drug Metab.</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">457</span> <span class="NLM_lpage">466</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.2174%2F138920006777697981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=16787155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVajtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=457-466&author=E.+H.+Kernsauthor=L.+Di&title=Utility+of+mass+spectrometry+for+pharmaceutical+profiling+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Utility of mass spectrometry for pharmaceutical profiling applications</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">457-466</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  MS has great utility for pharmaceutical profiling, the measurement of physicochem. and metabolic properties that are crucial to the discovery and development of new drug candidates.  An evaluation of the capabilities of MS to improve the speed, specificity, sensitivity and cost per compd. of method in development indicates when MS technologies have utility compared to other anal. techniques.  MS was used successfully for methods that profile the crit. properties: permeability, lipophilicity, plasma and soln. stability, soly., plasma protein binding and integrity.  In general, MS has utility in these methods using anal. strategies involving unique MS technologies (e.g., parallel multiplexed interfaces, trap-and-elute), orthogonal detection to UV, high sensitivity for low LOQs, low concn. studies, highly specific MS/MS SRM, combinatorial anal., use of internal stds., providing initial structural data in addn. to quant. and facile integration with HPLC autosamplers and other hardware that allow enhanced online expts.  Ultimately, it is important to evaluate the appropriateness of any technique that is being considered for use in a method, to insure that it best meets all of the criteria for the organization's needs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkScTOipViG7Vg90H21EOLACvtfcHk0lhhVsD9awz5ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVajtLs%253D&md5=30a83a479880d9162f5519ef459d82ef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2174%2F138920006777697981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920006777697981%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26atitle%3DUtility%2520of%2520mass%2520spectrometry%2520for%2520pharmaceutical%2520profiling%2520applications%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2006%26volume%3D7%26spage%3D457%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span> </span><span class="NLM_article-title">High throughput screening of metabolic stability in drug discovery</span> <span class="citation_source-journal">Am. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">2</span> <span class="NLM_fpage">28</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=28-32&author=L.+Diauthor=E.+H.+Kerns&title=High+throughput+screening+of+metabolic+stability+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26atitle%3DHigh%2520throughput%2520screening%2520of%2520metabolic%2520stability%2520in%2520drug%2520discovery%26jtitle%3DAm.%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D28%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, P.</span><span> </span><span class="NLM_article-title">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">93</span> <span class="NLM_fpage">1440</span> <span class="NLM_lpage">1453</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1002%2Fjps.20075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15124203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks12iu7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2004&pages=1440-1453&author=E.+H.+Kernsauthor=L.+Diauthor=S.+Petuskyauthor=M.+Farrisauthor=R.+Leyauthor=P.+Jupp&title=Combined+application+of+parallel+artificial+membrane+permeability+assay+and+Caco-2+permeability+assays+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery</span></div><div class="casAuthors">Kerns, Edward H.; Di, Li; Petusky, Susan; Farris, Michele; Ley, Rob; Jupp, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1440-1453</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Data from permeability profiling using the parallel artificial membrane permeability assay (PAMPA) and cell monolayer (Caco-2 and MDR1-MDCKII) methods were compared for two published compd. sets and one inhouse set.  A majority of compds. in each set correlated (R2 = 0.76-0.92), indicating the predominance of passive diffusion in the permeation of these compds.  Compds. that did not correlate grouped into two subsets.  One subset had higher PAMPA permeability than cell monolayer permeability and consisted of compds. that are subject to secretory mechanisms: efflux or reduced passive diffusion of bases under Caco-2 when run under a pH gradient.  The other subset had higher cell monolayer permeability than PAMPA permeability and consisted of compds. that are subject to absorptive mechanisms: paracellular, active transport, or increased passive diffusion of acids under Caco-2 when run under a pH gradient.  Given the characteristics of the two methods, these studies suggest how PAMPA and Caco-2 can be synergistically applied for efficient and rapid investigation of permeation mechanisms in drug discovery.  During early discovery, all compds. can be rapidly screened using PAMPA at low pH and neutral pH to assess passive diffusion permeability to indicate potential for gastrointestinal and cell assay permeation.  During intermediate discovery, selected compds. can be addnl. assayed by apical-to-basolateral Caco-2, which, in combination with PAMPA data, indicates susceptibility to addnl. permeation mechanisms (secretory and absorptive).  During mid-to-late discovery, selected candidates can be examd. in detail via multiple directional Caco-2 expts. and with transporter inhibitors for complete characterization of permeation mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1M-v5UG2RLVg90H21EOLACvtfcHk0lhhVsD9awz5ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks12iu7w%253D&md5=428596e93f30763e94ced9341d23a02e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Fjps.20075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20075%26sid%3Dliteratum%253Aachs%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DPetusky%26aufirst%3DS.%26aulast%3DFarris%26aufirst%3DM.%26aulast%3DLey%26aufirst%3DR.%26aulast%3DJupp%26aufirst%3DP.%26atitle%3DCombined%2520application%2520of%2520parallel%2520artificial%2520membrane%2520permeability%2520assay%2520and%2520Caco-2%2520permeability%2520assays%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2004%26volume%3D93%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerns, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConnell, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonnenberg-Reines, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreft, A.</span><span> </span><span class="NLM_article-title">Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatograpy-tandem mass spectrometry</span> <span class="citation_source-journal">J. Pharm. Biomed. Anal.</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">34</span> <span class="NLM_fpage">359</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1016%2FS0731-7085%2803%2900523-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15013150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFaruw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2004&pages=359-368&author=M.+Y.+Zhangauthor=E.+H.+Kernsauthor=O.+McConnellauthor=J.+Sonnenberg-Reinesauthor=M.+M.+Zaleskaauthor=J.+S.+Jacobsenauthor=J.+Buteraauthor=A.+Kreft&title=Brain+and+plasma+exposure+profiling+in+early+drug+discovery+using+cassette+administration+and+fast+liquid+chromatograpy-tandem+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Brain and plasma exposure profiling in early drug discovery using cassette administration and fast liquid chromatography-tandem mass spectrometry</span></div><div class="casAuthors">Zhang, Mei-Yi; Kerns, Edward; McConnell, Oliver; Sonnenberg-Reines, June; Zaleska, Margaret M.; Jacobsen, J. Steven; Butera, John; Kreft, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A method using reverse phase liq. chromatog.-tandem mass spectrometry and cassette administration was developed for in vivo brain and plasma exposure profiling to assist early CNS drug discovery programs.  Three to 4 compds. were grouped in cassettes for dosing and anal.  Compds. in the cassettes were selected to minimize possible anal. interference from each other, as well as from their potential metabolites.  In order to improve the confidence of cassette administration, an analog of the study compds., with well-established brain penetration data, was included in each cassette as a "biol. internal std.".  Compds. were administered to rats by i.p. injection and extd. from plasma or brain homogenate by simple protein pptn.  Fast chromatog. sepn. was achieved by a short narrow-bore column at a flow rate of 1.0 mL/min with a fast gradient.  The brain penetration of the compds. was evaluated by comparing their Cmax and AUC values in brain and plasma.  This approach rapidly provided early brain penetration and plasma exposure information, thus making more of this data available to teams.  Comparing the brain exposures to the EC50 values (i.e. in vitro potency) of series compds. in the same discovery program provided another dimension of information to select lead compds. for future in vivo assessment.  The method described here was used for providing early brain penetration information in several CNS exploratory and discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3LoIREMMFFrVg90H21EOLACvtfcHk0lhhVsD9awz5ow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFaruw%253D%253D&md5=09adf6630a34e77b9f26b9ab0928a201</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0731-7085%2803%2900523-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0731-7085%252803%252900523-5%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%2BY.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DMcConnell%26aufirst%3DO.%26aulast%3DSonnenberg-Reines%26aufirst%3DJ.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DJacobsen%26aufirst%3DJ.%2BS.%26aulast%3DButera%26aufirst%3DJ.%26aulast%3DKreft%26aufirst%3DA.%26atitle%3DBrain%2520and%2520plasma%2520exposure%2520profiling%2520in%2520early%2520drug%2520discovery%2520using%2520cassette%2520administration%2520and%2520fast%2520liquid%2520chromatograpy-tandem%2520mass%2520spectrometry%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2004%26volume%3D34%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Techesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grams, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maskos, K.</span><span> </span><span class="NLM_article-title">Structural properties of matrix metalloproteinases</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">55</span> <span class="NLM_fpage">639</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1007%2Fs000180050320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=10357232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlWlurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=639&author=W.+Bodeauthor=C.+Fernandez-Catalanauthor=H.+Techescheauthor=F.+Gramsauthor=H.+Nagageauthor=K.+Maskos&title=Structural+properties+of+matrix+metalloproteinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural properties of matrix metalloproteinases</span></div><div class="casAuthors">Bode, W.; Fernandez-Catalan, C.; Tschesche, H.; Grams, F.; Nagase, H.; Maskos, K.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">639-652</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review is given with 89 refs. on the 3-dimensional structures and activity of MMPs.  Matrix metalloproteinases (MMPs) are involved in extracellular matrix degrdn.  Their proteolytic activity must be precisely regulated by their endogenous protein inhibitors, the tissue inhibitors of metalloproteinases (TIMPs).  Disruption of this balance results in serious diseases such as arthritis, tumor growth and metastasis.  Knowledge of the tertiary structures of the proteins involved is crucial for understanding their functional properties and interference with assocd. dysfunctions.  Within the last few years, several 3-dimensional MMP and MMP-TIMP structures became available, showing the domain organization, polypeptide fold and main specificity determinants.  Complexes of the catalytic MMP domains with various synthetic inhibitors enabled the structure-based design and improvement of high-affinity ligands, which might be elaborated into drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6phf288RNY7Vg90H21EOLACvtfcHk0lj3S-BIaOybLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlWlurw%253D&md5=aaafe8566dae1cbe0652ca5256f6ddd0</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1007%2Fs000180050320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050320%26sid%3Dliteratum%253Aachs%26aulast%3DBode%26aufirst%3DW.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DTechesche%26aufirst%3DH.%26aulast%3DGrams%26aufirst%3DF.%26aulast%3DNagage%26aufirst%3DH.%26aulast%3DMaskos%26aufirst%3DK.%26atitle%3DStructural%2520properties%2520of%2520matrix%2520metalloproteinases%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D1999%26volume%3D55%26spage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Maskos, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Catalan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourenkov, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartunik, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellestad, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolson, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauch, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, H. R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzner, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerretti, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">March, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paxton, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span> </span><span class="NLM_article-title">Crystal Structure of the Catalytic Domain of Human Tumor Necrosis Factor-Î± Converting Enzyme,</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci.,</span><span class="NLM_year" style="font-weight: bold;">1998</span> <span class="NLM_volume">95</span> <span class="NLM_fpage">3408</span> <span class="NLM_lpage">3412</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1073%2Fpnas.95.7.3408" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=9520379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1cXitlGqu7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=3408-3412&author=K.+Maskosauthor=C.+Fernandez-Catalanauthor=R.+Huberauthor=G.+P.+Bourenkovauthor=H.+Bartunikauthor=G.+A.+Ellestadauthor=P.+Reddyauthor=M.+F.+Wolsonauthor=C.+T.+Rauchauthor=B.+J.+Castnerauthor=R.+Davisauthor=H.+R.+G.+Clarkeauthor=M.+Petersenauthor=J.+N.+Fitznerauthor=D.+P.+Cerrettiauthor=C.+J.+Marchauthor=R.+J.+Paxtonauthor=R.+A+Blackauthor=W.+Bode&title=Crystal+Structure+of+the+Catalytic+Domain+of+Human+Tumor+Necrosis+Factor-%CE%B1+Converting+Enzyme%2C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the catalytic domain of human tumor necrosis factor-Î±-converting enzyme</span></div><div class="casAuthors">Maskos, Klaus; Fernandez-Catalan, Carlos; Huber, Robert; Bourenkov, Gleb P.; Bartunik, Hans; Ellestad, George A.; Reddy, Pranitha; Wolfson, Martin F.; Rauch, Charles T.; Castner, Beverly J.; Davis, Raymond; Clarke, Howard R. G.; Petersen, Melissa; Fitzner, Jeffrey N.; Cerretti, Douglas Pat; March, Carl J.; Paxton, Raymond J.; Black, Roy A.; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3408-3412</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Tumor necrosis factor-Î± (TNFÎ±) is a cytokine that induces protective inflammatory reactions and kills tumor cells but also causes severe damage when produced in excess, as in rheumatoid arthritis and septic shock.  Sol. TNFÎ± is released from its membrane-bound precursor by a membrane-anchored proteinase, recently identified as a multidomain metalloproteinase called TNF-Î±-converting enzyme or TACE.  We have cocrystd. the catalytic domain of TACE with a hydroxamic acid inhibitor and have solved its 2.0 Ã crystal structure.  This structure reveals a polypeptide fold and a catalytic zinc environment resembling that of the snake venom metalloproteinases, identifying TACE as a member of the adamalysin/ADAM family.  However, a no. of large insertion loops generate unique surface features.  The pro-TNFÎ± cleavage site fits to the active site of TACE but seems also to be detd. by its position relative to the base of the compact trimeric TNFÎ± cone.  The active-site cleft of TACE shares properties with the matrix metalloproteinases but exhibits unique features such as a deep S3' pocket merging with the S1' specificity pocket below the surface.  The structure thus opens a different approach toward the design of specific synthetic TACE inhibitors, which could act as effective therapeutic agents in vivo to modulate TNFÎ±-induced pathophysiol. effects, and might also help to control related shedding processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQkmDbGcCls7Vg90H21EOLACvtfcHk0lj3S-BIaOybLg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitlGqu7g%253D&md5=57628757fd53cc972a6fe701e549495f</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.7.3408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.7.3408%26sid%3Dliteratum%253Aachs%26aulast%3DMaskos%26aufirst%3DK.%26aulast%3DFernandez-Catalan%26aufirst%3DC.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBourenkov%26aufirst%3DG.%2BP.%26aulast%3DBartunik%26aufirst%3DH.%26aulast%3DEllestad%26aufirst%3DG.%2BA.%26aulast%3DReddy%26aufirst%3DP.%26aulast%3DWolson%26aufirst%3DM.%2BF.%26aulast%3DRauch%26aufirst%3DC.%2BT.%26aulast%3DCastner%26aufirst%3DB.%2BJ.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DClarke%26aufirst%3DH.%2BR.%2BG.%26aulast%3DPetersen%26aufirst%3DM.%26aulast%3DFitzner%26aufirst%3DJ.%2BN.%26aulast%3DCerretti%26aufirst%3DD.%2BP.%26aulast%3DMarch%26aufirst%3DC.%2BJ.%26aulast%3DPaxton%26aufirst%3DR.%2BJ.%26aulast%3DBlack%26aufirst%3DR.%2BA%26aulast%3DBode%26aufirst%3DW.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Catalytic%2520Domain%2520of%2520Human%2520Tumor%2520Necrosis%2520Factor-%25CE%25B1%2520Converting%2520Enzyme%252C%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%252C%26date%3D1998%26volume%3D95%26spage%3D3408%26epage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delos Santos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khafizova, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacEwan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salaski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE Inhibitors. Part 1. SAR of the Acyclic Sulfonamide Hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.,</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">13</span> <span class="NLM_fpage">2798</span> <span class="NLM_lpage">2803</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2798-2803&author=J.+I.+Levinauthor=J.+M.+Chenauthor=K.+Cheungauthor=D.+Coleauthor=C.+Cragoauthor=E.+Delos+Santosauthor=X.+Duauthor=G.+Khafizovaauthor=G.+MacEwanauthor=C.+Niuauthor=E.+J.+Salaskiauthor=A.+Zaskauthor=T.+Cummonsauthor=A.+Sungauthor=J.+Xuauthor=Y.+Zhangauthor=W.+Xuauthor=S.+Ayral-Kaloustianauthor=G.+Jinauthor=R.+Cowlingauthor=D.+Baroneauthor=K.+M.+Mohlerauthor=R.+A.+Blackauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+Inhibitors.+Part+1.+SAR+of+the+Acyclic+Sulfonamide+Hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DCheung%26aufirst%3DK.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DCrago%26aufirst%3DC.%26aulast%3DDelos%2BSantos%26aufirst%3DE.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DKhafizova%26aufirst%3DG.%26aulast%3DMacEwan%26aufirst%3DG.%26aulast%3DNiu%26aufirst%3DC.%26aulast%3DSalaski%26aufirst%3DE.%2BJ.%26aulast%3DZask%26aufirst%3DA.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DSung%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DMohler%26aufirst%3DK.%2BM.%26aulast%3DBlack%26aufirst%3DR.%2BA.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520Inhibitors.%2520Part%25201.%2520SAR%2520of%2520the%2520Acyclic%2520Sulfonamide%2520Hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%252C%26date%3D2003%26volume%3D13%26spage%3D2798%26epage%3D2803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laakso, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummons, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span> </span><span class="NLM_article-title">Acetylenic TACE Inhibitors. Part 3. Thiomorpholine Sulfonamide Hydroxamates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.,</span><span class="NLM_year" style="font-weight: bold;">2006</span> <span class="NLM_volume">16</span> <span class="NLM_fpage">1605</span> <span class="NLM_lpage">1609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1605-1609&author=J.+I.+Levinauthor=J.+M.+Chenauthor=L.+M.+Laaksoauthor=M.+Duauthor=J.+Schmidauthor=W.+Xuauthor=T.+Cummonsauthor=J.+Xuauthor=G.+Jinauthor=D.+Baroneauthor=J.+S.+Skotnicki&title=Acetylenic+TACE+Inhibitors.+Part+3.+Thiomorpholine+Sulfonamide+Hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DChen%26aufirst%3DJ.%2BM.%26aulast%3DLaakso%26aufirst%3DL.%2BM.%26aulast%3DDu%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DCummons%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DBarone%26aufirst%3DD.%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26atitle%3DAcetylenic%2520TACE%2520Inhibitors.%2520Part%25203.%2520Thiomorpholine%2520Sulfonamide%2520Hydroxamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%252C%26date%3D2006%26volume%3D16%26spage%3D1605%26epage%3D1609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Newman, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cragg, G. M.</span><span> </span><span class="NLM_article-title">Natural products as sources of new drugs over the last 25 years</span> <span class="citation_source-journal">J. Nat. Prod.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">70</span> <span class="NLM_fpage">461</span> <span class="NLM_lpage">477</span></span><div class="citationLinks">[<a href="/doi/10.1021/np068054v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=461-477&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Natural Products as Sources of New Drugs over the Last 25 Years</span></div><div class="casAuthors">Newman, David J.; Cragg, Gordon M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-477</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">A review.  This review is an updated and expanded version of two prior reviews that were published in this journal in 1997 and 2003.  In the case of all approved agents the time frame has been extended to include the 251/2 years from 01/1981 to 06/2006 for all diseases worldwide and from 1950 (earliest so far identified) to 06/2006 for all approved antitumor drugs worldwide.  We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions.  From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well.  Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 155 small mols., 73% are other than "S" (synthetic), with 47% actually being either natural products or directly derived therefrom.  In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the antiinfective area being dependent on natural products and their structures.  Although combinatorial chem. techniques have succeeded as methods of optimizing structures and have, in fact, been used in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compd. approved as a drug in this 25 plus year time frame.  We wish to draw the attention of readers to the rapidly evolving recognition that a significant no. of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpih5kusSUibVg90H21EOLACvtfcHk0lgd39dfxEoRGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFKrsro%253D&md5=9fc0909750367ccd3b97589aaf087cdf</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fnp068054v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp068054v%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%2520the%2520last%252025%2520years%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D461%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Koehn, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span> </span><span class="NLM_article-title">The evolving role of natural products in drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2005</span> <span class="NLM_volume">4</span> <span class="NLM_fpage">206</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnrd1657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15729362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=206-220&author=F.+E.+Koehnauthor=G.+T.+Carter&title=The+evolving+role+of+natural+products+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The evolving role of natural products in drug discovery</span></div><div class="casAuthors">Koehn, Frank E.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">206-220</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products and their derivs. have historically been invaluable as a source of therapeutic agents.  However, in the past decade, research into natural products in the pharmaceutical industry has declined, owing to issues such as the lack of compatibility of traditional natural-product ext. libraries with high-throughput screening.  However, as discussed in this review, recent technol. advances that help to address these issues, coupled with unrealized expectations from current lead-generation strategies, have led to a renewed interest in natural products in drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsRGIXVxX38LVg90H21EOLACvtfcHk0lgd39dfxEoRGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhslSnsrg%253D&md5=ce80052abaa76430220ee5981138053e</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnrd1657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1657%26sid%3Dliteratum%253Aachs%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DThe%2520evolving%2520role%2520of%2520natural%2520products%2520in%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D206%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Kanafani, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corey, G. R.</span><span> </span><span class="NLM_article-title">Daptomycin: a rapidly bactericidal lipopeptide for the treatment of gram-positive infections</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">5</span> <span class="NLM_fpage">177</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1586%2F14787210.5.2.177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=17402833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjs12ktLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=177-184&author=Z.+A.+Kanafaniauthor=G.+R.+Corey&title=Daptomycin%3A+a+rapidly+bactericidal+lipopeptide+for+the+treatment+of+gram-positive+infections"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections</span></div><div class="casAuthors">Kanafani, Zeina A.; Corey, G. Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Antimicrobial resistance among Gram-pos. organisms continues to increase and has reached epidemic proportions in a no. of countries and within medical centers worldwide.  Daptomycin is a new lipopeptide antibiotic with rapid bactericidal activity against Staphylococcus aureus.  It is also active against coagulase-neg. staphylococci, enterococci and streptococci.  It exerts its effect through cell membrane disruption that results in dissipation of the membrane potential.  Daptomycin exhibits a prolonged postantibiotic effect and is well tolerated.  In Phase III clin. trials, daptomycin was found to be similar in efficacy to std. therapy in complicated skin and skin structure infections.  More recently, it was approved for the treatment of S. aureus bacteremia and right-sided endocarditis.  Daptomycin is not indicated for pulmonary infections.  Preliminary data suggest that daptomycin may be effective in urinary tract, bone and joint infections.  However, randomized clin. trials are needed to confirm these findings.  Daptomycin is an effective antimicrobial agent for the treatment of various serious Gram-pos. infections, esp. those caused by methicillin-resistant S. aureus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5cJNFOvyjX7Vg90H21EOLACvtfcHk0lgd39dfxEoRGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjs12ktLs%253D&md5=bd7b8c5b11acd9f1cecde9a66893fb97</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1586%2F14787210.5.2.177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14787210.5.2.177%26sid%3Dliteratum%253Aachs%26aulast%3DKanafani%26aufirst%3DZ.%2BA.%26aulast%3DCorey%26aufirst%3DG.%2BR.%26atitle%3DDaptomycin%253A%2520a%2520rapidly%2520bactericidal%2520lipopeptide%2520for%2520the%2520treatment%2520of%2520gram-positive%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2007%26volume%3D5%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Sehgal, S. N.</span><span> </span><span class="NLM_article-title">Sirolimus: Its Discovery, Biological Properties and Mechanism of Action</span> <span class="citation_source-journal">Transplantation Proc.</span><span class="NLM_year" style="font-weight: bold;">2003</span> <span class="NLM_volume">35</span> <span class="NLM_fpage">7S</span> <span class="NLM_lpage">14S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=7S-14S&author=S.+N.+Sehgal&title=Sirolimus%3A+Its+Discovery%2C+Biological+Properties+and+Mechanism+of+Action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSehgal%26aufirst%3DS.%2BN.%26atitle%3DSirolimus%253A%2520Its%2520Discovery%252C%2520Biological%2520Properties%2520and%2520Mechanism%2520of%2520Action%26jtitle%3DTransplantation%2520Proc.%26date%3D2003%26volume%3D35%26spage%3D7S%26epage%3D14S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Structure of the FKBP12ârapamycin complex interacting with the binding domain of human FRAP</span> <span class="citation_source-journal">Science</span><span class="NLM_year" style="font-weight: bold;">1996</span> <span class="NLM_volume">273</span> <span class="NLM_fpage">239</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12%E2%88%92rapamycin+complex+interacting+with+the+binding+domain+of+human+FRAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%2520complex%2520interacting%2520with%2520the%2520binding%2520domain%2520of%2520human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D239%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Skotnicki, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Discafani, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M. A.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Biological Evaluation C-42 Hydroxyesters of Rapamycin: The Identification of CCI-779</span> <span class="citation_source-journal">Clinical Cancer Res.,</span><span class="NLM_year" style="font-weight: bold;">2001</span> <span class="NLM_volume">7</span> <span class="NLM_fpage">3749S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2001&pages=3749S&author=J.+S.+Skotnickiauthor=C.+L.+Leoneauthor=A.+L.+Smithauthor=Y.+L.+Palmerauthor=K.+Yuauthor=C.+M.+Discafaniauthor=J.+J.+Gibbonsauthor=P.+Frostauthor=M.+A.+Abou-Gharbia&title=Design%2C+Synthesis+and+Biological+Evaluation+C-42+Hydroxyesters+of+Rapamycin%3A+The+Identification+of+CCI-779"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkotnicki%26aufirst%3DJ.%2BS.%26aulast%3DLeone%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BL.%26aulast%3DPalmer%26aufirst%3DY.%2BL.%26aulast%3DYu%26aufirst%3DK.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%2BA.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Biological%2520Evaluation%2520C-42%2520Hydroxyesters%2520of%2520Rapamycin%253A%2520The%2520Identification%2520of%2520CCI-779%26jtitle%3DClinical%2520Cancer%2520Res.%252C%26date%3D2001%26volume%3D7%26spage%3D3749S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ma, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimeno, A.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of C-42 hydroxyesters of rapamycin: the identification of CCI-779</span> <span class="citation_source-journal">Drugs Today</span><span class="NLM_year" style="font-weight: bold;">2007</span> <span class="NLM_volume">43</span> <span class="NLM_fpage">659</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1358%2Fdot.2007.43.10.1148059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVCm" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2007&pages=659-669&author=W.+W.+Maauthor=A.+Jimeno&title=Design%2C+synthesis+and+biological+evaluation+of+C-42+hydroxyesters+of+rapamycin%3A+the+identification+of+CCI-779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Temsirolimus</span></div><div class="casAuthors">Ma, Wen W.; Jimeno, Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of Today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">659-669</span>CODEN:
                <span class="NLM_cas:coden">MDACAP</span>;
        ISSN:<span class="NLM_cas:issn">1699-3993</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Temsirolimus (CCI-779), a small mol. inhibitor of mTOR protein, is a water-sol. synthetic rapamycin ester that has been developed in both oral and i.v. (i.v.) formulations.  PI3k/Akt/mTOR pathway activation is implicated in the pathogenesis of many cancers.  Inhibition of mTOR protein abrogates pathway-mediated cellular transcription and translation, leading to cell cycle arrest, antiangiogenesis and apoptosis.  The drug has significant in vitro antitumor effect against a no. of cancer cell lines and has demonstrated in vivo cytostatic activity in xenograft models.  Flat dosing of 25 mg, 75 mg and 250 mg i.v. weekly were selected for tumor-specific phase I trials.  Biol. activity was obsd. at all these doses.  However, the frequency and intensity of the toxicities increased at higher doses and more high-dose patients had to reduce the dose or discontinue the drug.  Notable temsirolimus-related toxicities include rash, mucostomatitis, diarrhea, hyperlipidemia, hyperglycemia and thrombocytopenia.  Temsirolimus is farther along in clin. development than any other mTOR inhibitor in its class and has demonstrated significant activity in patients with poor-risk clear-cell renal cell carcinoma.  Patients receiving temsirolimus alone achieved longer survival than those receiving interferon alone or temsirolimus plus interferon in a randomized phase III trial.  Predictive biomarkers for clin. efficacy are undetd. and remain under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWPz_d4Lo4kbVg90H21EOLACvtfcHk0lhQWH2IHqlUyQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVCm&md5=af7659bf35464f266b7f8ec1e9f6c95b</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1358%2Fdot.2007.43.10.1148059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdot.2007.43.10.1148059%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DW.%2BW.%26aulast%3DJimeno%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520C-42%2520hydroxyesters%2520of%2520rapamycin%253A%2520the%2520identification%2520of%2520CCI-779%26jtitle%3DDrugs%2520Today%26date%3D2007%26volume%3D43%26spage%3D659%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Snyder, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Immunophilins and the nervous system</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_year" style="font-weight: bold;">1995</span> <span class="NLM_fpage">32</span> <span class="NLM_lpage">37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=32-37&author=S.+H.+Snyderauthor=D.+M.+Sabatini&title=Immunophilins+and+the+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DImmunophilins%2520and%2520the%2520nervous%2520system%26jtitle%3DNature%2520Med.%26date%3D1995%26spage%3D32%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Sharkey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, S. P.</span><span> </span><span class="NLM_article-title">Immunophilins mediate the neuroprotective effects of FK-506 in focal cerebral ischemia</span> <span class="citation_source-journal">Nature</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">371</span> <span class="NLM_fpage">336</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=1994&pages=336-339&author=J.+Sharkeyauthor=S.+P.+Butcher&title=Immunophilins+mediate+the+neuroprotective+effects+of+FK-506+in+focal+cerebral+ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSharkey%26aufirst%3DJ.%26aulast%3DButcher%26aufirst%3DS.%2BP.%26atitle%3DImmunophilins%2520mediate%2520the%2520neuroprotective%2520effects%2520of%2520FK-506%2520in%2520focal%2520cerebral%2520ischemia%26jtitle%3DNature%26date%3D1994%26volume%3D371%26spage%3D336%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Steiner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hestu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Neurotrophic actions of nonimmunosuppressive analogs of immunosuppressive drugs FK-506, rapamycin and cyclosporin</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_year" style="font-weight: bold;">1997</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">421</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnm0497-421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=9095176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK2sXit1Cktbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=421-428&author=J.+P.+Steinerauthor=M.+A.+Connollyauthor=H.+L.+Valentineauthor=G.+S.+Hamiltonauthor=T.+M.+Dawsonauthor=L.+Hestuauthor=S.+H.+Snyder&title=Neurotrophic+actions+of+nonimmunosuppressive+analogs+of+immunosuppressive+drugs+FK-506%2C+rapamycin+and+cyclosporin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophic actions of non-immunosuppressive analogs of immunosuppressive drugs FK506, rapamycin and cyclosporin A</span></div><div class="casAuthors">Steiner, Joseph P.; Connolly, Maureen A.; Valentine, heather L.; Hamilton, Gregory S.; Dawson, Ted M.; Hester, Lynda; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-428</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">We show that the non-immunosuppressive analogs of the immunosuppressive drugs FK506, rapamycin and cyclosporin A promote neurite outgrowth both in PC12 cells and sensory neuronal cultures of dorsal root ganglia with potencies resembling their immunosuppressive homologues.  Neurotrophic potencies of the immunophilin ligands resemble their potencies in binding to and inhibiting the rotamase activity of FKBP-12 or cyclophilin.  Since nonimmunosuppressive immunophilin ligands, which are devoid of calcineurin inhibitory activity, are equally neurotrophic, inhibition of calcineurin activity is not the mediator of the neurotrophic effects.  The immunophilin ligands are neurotrophic in intact animals.  FK506 and L-685,818 (the C18-hydroxy, C21-Et deriv. of FK506) treatment of rats with crushed sciatic nerves enhances both functional and morphol. recovery.  The striking potency of these agents, their bioavailability and the dissocn. of neurotrophic from immunosuppressant actions argue for their therapeutic relevance in the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohOa5nM7tRtbVg90H21EOLACvtfcHk0lhYY81wYGOU1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXit1Cktbo%253D&md5=5490b2739cf699ec8b870c090c35fb5a</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fnm0497-421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm0497-421%26sid%3Dliteratum%253Aachs%26aulast%3DSteiner%26aufirst%3DJ.%2BP.%26aulast%3DConnolly%26aufirst%3DM.%2BA.%26aulast%3DValentine%26aufirst%3DH.%2BL.%26aulast%3DHamilton%26aufirst%3DG.%2BS.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DHestu%26aufirst%3DL.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DNeurotrophic%2520actions%2520of%2520nonimmunosuppressive%2520analogs%2520of%2520immunosuppressive%2520drugs%2520FK-506%252C%2520rapamycin%2520and%2520cyclosporin%26jtitle%3DNat.%2520Med.%26date%3D1997%26volume%3D3%26spage%3D421%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Gold, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Densmore, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matzuk, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, H. S. J.</span><span> </span><span class="NLM_article-title">Immunophilin FK506-binding protein FKBP-52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_year" style="font-weight: bold;">1999</span> <span class="NLM_volume">289</span> <span class="NLM_fpage">1202</span> <span class="NLM_lpage">1210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=10336507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADyaK1MXjtlGgu7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=1999&pages=1202-1210&author=B.+G.+Goldauthor=V.+Densmoreauthor=W.+Shouauthor=M.+M.+Matzukauthor=H.+S.+J.+Gordon&title=Immunophilin+FK506-binding+protein+FKBP-52+%28not+FK506-binding+protein+12%29+mediates+the+neurotrophic+action+of+FK506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506</span></div><div class="casAuthors">Gold, Bruce G.; Densmore, Valerie; Shou, Weinian; Matzuk, Martin M.; Gordon, Heidi S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1202-1210</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The neurotrophic property of the immunosuppressant drug FK506 (tacrolimus) is believed to depend on the 12-kDa FK506-binding protein (FKBP-12).  Here, we show that FK506 maintains its neurotrophic activity in primary hippocampal cell cultures from FKBP-12 knockout mice.  In human neuroblastoma SH-SY5Y cells, the neurotrophic action of FK506 (10 pM to 10 nM) is completely prevented by the addn. of a monoclonal antibody (50-100 nM) to the immunophilin FKBP-52 (also known as FKBP-59 or heat shock protein 56), a component of mature steroid receptor complexes.  By itself, the FKBP-52 antibody is also neurotrophic.  The neurotrophic activity of dexamethasone (50 nM) is potentiated by FK506, whereas that of Î²-estradiol (50 nM) is not altered, suggesting a common mechanisms of action.  Geldanamycin (which disrupts mature steroid receptor complexes) is also neurotrophic (0.1-10 nM), whereas it reduces the neurotrophic activity of FK506 and steroid hormones (dexamethasone and Î²-estradiol).  Conversely, 20 mM molybdate (which prevents the disruption of mature steroid receptor complexes) decreases the neurotrophic activity of FK506, FKBP-52 antibody, dexamethasone, and Î²-estradiol.  In rats, FK506 (10 mg/kg s.c.) augments the regenerative response of regenerating motor and sensory neurons to nerve injury as shown by its ability to increase the axotomy-induced induction of c-jun expression.  A model is proposed to account for the neurotrophic action of both neuroimmunophilin ligands (FK506) and steroid hormones.  Components of steroid receptor complexes represent novel targets for the rational design of new neurotrophic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlLoqLj-LqdLVg90H21EOLACvtfcHk0lhYY81wYGOU1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtlGgu7Y%253D&md5=1b7762e53fd5af081ddc4ab51276bf9c</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGold%26aufirst%3DB.%2BG.%26aulast%3DDensmore%26aufirst%3DV.%26aulast%3DShou%26aufirst%3DW.%26aulast%3DMatzuk%26aufirst%3DM.%2BM.%26aulast%3DGordon%26aufirst%3DH.%2BS.%2BJ.%26atitle%3DImmunophilin%2520FK506-binding%2520protein%2520FKBP-52%2520%2528not%2520FK506-binding%2520protein%252012%2529%2520mediates%2520the%2520neurotrophic%2520action%2520of%2520FK506%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1999%26volume%3D289%26spage%3D1202%26epage%3D1210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Lyons, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, S. H.</span><span> </span><span class="NLM_article-title">Immunosuppressant FK-506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">1994</span> <span class="NLM_volume">91</span> <span class="NLM_fpage">3191</span> <span class="NLM_lpage">3195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=3191-3195&author=W.+E.+Lyonsauthor=E.+B.+Georgeauthor=T.+M.+Dawsonauthor=J.+P.+Steinerauthor=S.+H.+Snyder&title=Immunosuppressant+FK-506+promotes+neurite+outgrowth+in+cultures+of+PC12+cells+and+sensory+ganglia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLyons%26aufirst%3DW.%2BE.%26aulast%3DGeorge%26aufirst%3DE.%2BB.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DSteiner%26aufirst%3DJ.%2BP.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DImmunosuppressant%2520FK-506%2520promotes%2520neurite%2520outgrowth%2520in%2520cultures%2520of%2520PC12%2520cells%2520and%2520sensory%2520ganglia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1994%26volume%3D91%26spage%3D3191%26epage%3D3195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Ruan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jow, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crozier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaleska, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skotnicki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehn, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abou-Gharbia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graziani, E. I.</span><span> </span><span class="NLM_article-title">Binding of rapamycin analogs to calcium channels and FKBP52 contributes to their neuroprotective activities</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_year" style="font-weight: bold;">2008</span> <span class="NLM_volume">105</span><span class="NLM_issue">1</span> <span class="NLM_fpage">33</span> <span class="NLM_lpage">38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=33-38&issue=1&author=B.+Ruanauthor=K.+Pongauthor=F.+Jowauthor=M.+Bowlbyauthor=R.+A.+Crozierauthor=D.+Liuauthor=M.+M.+Zaleskaauthor=A.+Woodauthor=P.+H.+Reinhartauthor=R.+Magoldaauthor=J.+Skotnickiauthor=M.+N.+Pangalosauthor=F.+E.+Koehnauthor=G.+T.+Carterauthor=M.+Abou-Gharbiaauthor=E.+I.+Graziani&title=Binding+of+rapamycin+analogs+to+calcium+channels+and+FKBP52+contributes+to+their+neuroprotective+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuan%26aufirst%3DB.%26aulast%3DPong%26aufirst%3DK.%26aulast%3DJow%26aufirst%3DF.%26aulast%3DBowlby%26aufirst%3DM.%26aulast%3DCrozier%26aufirst%3DR.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DReinhart%26aufirst%3DP.%2BH.%26aulast%3DMagolda%26aufirst%3DR.%26aulast%3DSkotnicki%26aufirst%3DJ.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26aulast%3DKoehn%26aufirst%3DF.%2BE.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26aulast%3DAbou-Gharbia%26aufirst%3DM.%26aulast%3DGraziani%26aufirst%3DE.%2BI.%26atitle%3DBinding%2520of%2520rapamycin%2520analogs%2520to%2520calcium%2520channels%2520and%2520FKBP52%2520contributes%2520to%2520their%2520neuroprotective%2520activities%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26issue%3D1%26spage%3D33%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Pong, K.; Graziani, E.; Liang, S.; Liu, D.; Chen, Y.; Gonzales, C.; McIlvain, H. D.; Reinhart, P. H.; Pangalos, M. N.; Ruan, B.; Skotnicki, J.; Koehn, F.; Carter, G.; Magolda, R.; Abou-Gharbia, M.; Zaleska, M. M.; Wood, A.</span><span> </span><span class="NLM_article-title">ILS-920, a Novel, Nonimmunosuppressive Rapamycin Analog, Stimulates Neuronal Survival and Outgrowth and Promotes Cellular and Functional Recovery following Cerebral Ischemia</span>. Presented at the 22th Annual Meeting of the Society for Neuroscience, <span class="NLM_year">2007</span>, San Diego, CA; Poster 598.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=K.+Pong&author=E.+Graziani&author=S.+Liang&author=D.+Liu&author=Y.+Chen&author=C.+Gonzales&author=H.+D.+McIlvain&author=P.+H.+Reinhart&author=M.+N.+Pangalos&author=B.+Ruan&author=J.+Skotnicki&author=F.+Koehn&author=G.+Carter&author=R.+Magolda&author=M.+Abou-Gharbia&author=M.+M.+Zaleska&author=A.+Wood&title=ILS-920%2C+a+Novel%2C+Nonimmunosuppressive+Rapamycin+Analog%2C+Stimulates+Neuronal+Survival+and+Outgrowth+and+Promotes+Cellular+and+Functional+Recovery+following+Cerebral+Ischemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPong%26aufirst%3DK.%26atitle%3DILS-920%252C%2520a%2520Novel%252C%2520Nonimmunosuppressive%2520Rapamycin%2520Analog%252C%2520Stimulates%2520Neuronal%2520Survival%2520and%2520Outgrowth%2520and%2520Promotes%2520Cellular%2520and%2520Functional%2520Recovery%2520following%2520Cerebral%2520Ischemia%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Rees, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span> </span><span class="NLM_article-title">Fragment-based lead discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_year" style="font-weight: bold;">2004</span> <span class="NLM_volume">3</span> <span class="NLM_fpage">660</span> <span class="NLM_lpage">672</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm8012823&amp;key=10.1038%2Fnrd1467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm8012823&amp;key=15286733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm8012823&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=660-672&author=D.+C.+Reesauthor=M.+Congreveauthor=W.+Murrayauthor=R.+Carr&title=Fragment-based+lead+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based lead discovery</span></div><div class="casAuthors">Rees, David C.; Congreve, Miles; Murray, Christopher W.; Carr, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">660-672</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Fragment-based lead discovery is gaining momentum in both large pharmaceutical companies and biotechnol. labs. as a complementary approach to traditional screening.  This is because fragment-based approaches require significantly fewer compds. to be screened and synthesized, and are showing a high success rate in generating chem. series with lead-like properties.  Compared with traditional screening hits, the starting fragments have considerably lower mol. mass, and although the binding interactions of these fragments with a target protein are weak, they are structurally understood through x-ray crystallog. or NMR, and they exhibit high 'ligand efficiency'.  Here, the authors use examples from 25 different protein targets to describe chem. strategies that exploit this structural knowledge to rapidly develop fragments into high-affinity leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbKeUzFFIlhbVg90H21EOLACvtfcHk0lhbFew0yORuiQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVOht7Y%253D&md5=8d49ac7f698c9b9d573ee3c3485eced8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fnrd1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1467%26sid%3Dliteratum%253Aachs%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DMurray%26aufirst%3DW.%26aulast%3DCarr%26aufirst%3DR.%26atitle%3DFragment-based%2520lead%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D660%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm8012823&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Fjm8012823%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-1%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm8012823" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993e82fc1fd93e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
